Memory loss

MEMLOSS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R41.1, R41.2, R41.3 Cause of death: ICD-10 — R41.1, R41.2, R41.3 2 out of 7 registries used, show all original rules.	3647
4. Check minimum number of events None	3647
5. Include endpoints None	3647
6. Filter based on genotype QC (FinnGen only)	3544

Control definitions (FinnGen only)

Control exclude: F5_DEMENTIA, G6_ALZHEIMER, G6_AD_STRICT

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	MEMLOSS
CONTROL_EXCLUDE	F5_DEMENTIA\|G6_ALZHEIMER\|G6_AD_STRICT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R41[1-3]
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R41[1-3]
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Memory loss based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3544	1882	1662
Unadjusted period prevalence (%)	0.71	0.67	0.76
Median age at first event (years)	69.05	68.17	70.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3647: Matched controls
36470

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N06DA04

ATC

galantamine; oral

118.7

312.6

159

G45.4

ICD-10 Finland

Transient global amnesia

10.1

308.6

365

396

R41.3

ICD-10 Finland

Other amnesia

4302.6

307.7

3482

178

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

94.1

307.7

196

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

14.7

307.7

1496

1646

N06DA03

ATC

rivastigmine; oral, transdermal

112.5

307.7

445

XA800

NOMESCO Finland

Neuropsychological investigation

14.4

307.7

554

447

N06DA02

ATC

donepezil; oral

105.8

307.7

602

N06DX01

ATC

memantine; oral

142.9

307.7

795

P20

ICPC

Memory disturbance

4.9

307.7

1055

2806

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

18.8

307.7

266

152

G30.1

ICD-10 Finland

Alzheimer disease with late onset

182.4

307.7

799

F03

ICD-10 Finland

Unspecified dementia

27.2

307.7

357

145

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

346.6

285.0

285

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

283.1

268

N05AX08

ATC

risperidone; systemic

6.2

277.5

523

962

G30.8

ICD-10 Finland

Other Alzheimer disease

104.7

273.6

141

Z2221

NOMESCO Finland

Medical doctor

3.3

265.0

1560

6682

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

3.3

259.2

1545

6650

Z01.9

ICD-10 Finland

Special examination, unspecified

5.5

241.2

518

1071

R4110

NOMESCO Finland

Physiotherapy

3.1

240.5

1594

7232

F06.7

ICD-10 Finland

Mild cognitive disorder

8.7

239.8

317

395

P70

ICPC

Dementia

17.2

189.6

158

AA1AD

NOMESCO Finland

CT of head and brain

2.7

185.5

1559

7791

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

4.1

180.7

562

1551

Z3226

NOMESCO Finland

Physiotherapist

2.9

173.2

1061

4466

N05AH04

ATC

quetiapine; oral

3.3

170.5

767

2700

A28

ICPC

Limited function/disability NOS

2.9

170.2

1126

4933

N06AX11

ATC

mirtazapine; oral

2.6

162.1

1568

8265

TAB00

NOMESCO Finland

Lumbar puncture

5.9

157.3

295

533

ZXD10

NOMESCO Finland

Scheduled procedure

2.5

153.4

1841

10648

Z3231

NOMESCO Finland

Registered nurse

2.5

146.7

1402

7273

N03AG01

ATC

valproic acid; systemic, rectal

5.0

144.4

334

727

R41.2

ICD-10 Finland

Retrograde amnesia

490.0

143.4

142

F01.9

ICD-10 Finland

Vascular dementia, unspecified

30.1

142.3

G30

ICD-10 Finland

Alzheimer disease

215.6

140.9

145

Z71.8

ICD-10 Finland

Other specified counselling

2.5

140.4

1353

7015

Z2445

NOMESCO Finland

Psychologist

6.5

136.8

230

372

R53

ICD-10 Finland

Malaise and fatigue

2.5

134.2

1152

5641

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

128.9

898

3966

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.5

126.6

1015

4794

R5110, ,

SPAT

3.5

121.5

461

1440

SPAT1053

SPAT

Memory test

2.6

120.7

851

3767

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

24.8

120.4

ZXD35

NOMESCO Finland

Usual procedure

5.1

120.0

264

549

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.2

115.7

528

1846

XF400

NOMESCO Finland

ECG with 12 standard connections

2.5

111.8

914

4324

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.4

111.2

455

1488

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.7

105.7

361

1049

U13

ICPC

Bladder symptom/complaint other

4.8

102.3

240

526

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

101.1

562

2187

R41.0

ICD-10 Finland

Disorientation, unspecified

5.1

100.6

222

462

F01.2

ICD-10 Finland

Subcortical vascular dementia

49.1

99.8

R42

ICD-10 Finland

Dizziness and giddiness

2.2

98.1

1145

6260

ZXE00

NOMESCO Finland

One hour or less

2.1

96.5

1633

10271

WX002

NOMESCO Finland

Sedation and analgesia

2.2

92.9

990

5198

F05.1

ICD-10 Finland

Delirium superimposed on dementia

48.9

91.0

Z01.7

ICD-10 Finland

Laboratory examination

2.5

91.0

695

3155

N06AB10

ATC

escitalopram; oral

2.4

90.5

720

3329

N05AH03

ATC

olanzapine; systemic

4.0

90.0

274

733

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.8

88.3

207

453

N06AB04

ATC

citalopram; systemic

2.3

87.9

895

4598

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.8

87.9

503

1979

WX110, ,

SPAT

3.5

83.4

300

899

ZXA05

NOMESCO Finland

Left side

2.0

82.8

1204

7073

N03AF02

ATC

oxcarbazepine; oral

4.7

81.6

196

437

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.6

79.3

280

828

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

27.4

79.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

78.5

1377

8604

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.5

78.3

542

2338

ZXA00

NOMESCO Finland

Right side

2.0

77.8

1255

7613

G30.0

ICD-10 Finland

Alzheimer disease with early onset

774.6

77.6

XCK10

NOMESCO Finland

Photography of fundus of eye

2.5

77.4

550

2401

EB1AA, ,

SPAT

3.2

76.8

328

1093

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

73.1

1511

9908

S06.0

ICD-10 Finland

Concussion

2.6

72.6

480

2021

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

10.2

70.9

Z2446

NOMESCO Finland

Social worker

3.0

70.6

333

1174

R51.80

ICD-10 Finland

Headache

2.3

68.5

598

2852

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.6

68.3

236

687

WX892

NOMESCO Finland

Monitored bed care

2.6

67.9

421

1715

ZXY02

NOMESCO Finland

Neuropsychologist

15.9

67.5

N06AX26

ATC

vortioxetine; oral

3.3

66.2

264

842

ZXD20

NOMESCO Finland

Day surgery

2.3

65.7

577

2755

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

649.6

65.1

R41.1

ICD-10 Finland

Anterograde amnesia

+∞

64.8

N03AX09

ATC

lamotrigine; oral

4.2

64.6

176

433

N06AX16

ATC

venlafaxine; oral

2.4

63.1

498

2268

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

60.8

1139

7141

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.4

60.7

464

2081

G31.0

ICD-10 Finland

Circumscribed brain atrophy

14.3

60.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

60.4

892

5172

R4120

NOMESCO Finland

Occupational therapy

2.8

60.1

317

1186

KMAK, ,

NOMESCO Finland

1.7

57.6

1677

11937

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4.0

57.6

169

439

R55

ICD-10 Finland

Syncope and collapse

2.2

57.4

549

2705

F32

ICD-10 Finland

Depressive episode

3.5

57.1

204

606

F05.9

ICD-10 Finland

Delirium, unspecified

4.5

55.2

136

309

XF606

NOMESCO Finland

Ortostatic test

8.0

54.5

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

53.6

410

1835

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

8.8

53.5

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

16.3

53.0

Z73.6

ICD-10 Finland

Limitation of activities due to disability

6.9

52.6

122

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.8

51.2

118

254

N06AB06

ATC

sertraline; oral

2.4

50.8

385

1714

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

50.2

394

1781

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.6

49.3

167

479

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

48.7

921

5724

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

48.2

277

1081

M79.6

ICD-10 Finland

Pain in limb

1.7

47.6

1512

10844

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.6

47.0

114

256

N05BA04

ATC

oxazepam; oral

1.8

46.4

959

6106

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

46.3

314

1328

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

46.0

414

1981

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

45.5

1162

7844

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

45.2

990

6401

N05BA01

ATC

diazepam; systemic, rectal

2.0

45.1

552

2969

N06AX21

ATC

duloxetine; oral

2.2

44.9

437

2156

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

5.9

44.6

141

Z71.9

ICD-10 Finland

Counselling, unspecified

2.5

44.4

299

1259

A11

ICPC

Chest pain NOS

2.2

44.1

401

1925

A04

ICPC

Weakness/tiredness general

1.9

44.0

602

3363

A23

ICPC

Risk factor NOS

2.5

43.8

297

1255

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

42.9

671

3913

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

151.8

42.9

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.1

42.7

181

597

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.4

42.0

107

250

N30.0

ICD-10 Finland

Acute cystitis

1.9

41.9

646

3747

A98

ICPC

Health maint/preventive medicine

2.4

41.9

3383

30733

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

6.7

41.6

100

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

40.6

257

1050

W19

ICD-10 Finland

Unspecified fall

2.1

40.5

410

2051

N30

ICD-10 Finland

Cystitis

2.3

40.5

333

1532

F34.1

ICD-10 Finland

Dysthymia

3.5

40.3

143

423

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

40.2

518

2828

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

40.1

208

769

R4130

NOMESCO Finland

Speech therapy

3.5

39.9

139

406

EB1SA, ,

SPAT

2.9

39.7

195

700

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.3

39.3

323

1485

N03AX14

ATC

levetiracetam; systemic

3.5

39.2

136

396

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

39.2

680

4086

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.3

39.0

102

243

EBA00, ,

SPAT

3.5

38.9

136

398

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

38.7

2338

19223

K59.0

ICD-10 Finland

Constipation

2.4

38.7

277

1198

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

38.7

281

1224

M25.5

ICD-10 Finland

Pain in joint

1.7

38.6

1066

7280

N17

ICPC

Vertigo/dizziness

1.9

38.6

543

3051

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.9

38.5

536

3001

U72

ICPC

Urethritis

3.6

38.3

130

373

N05AX12

ATC

aripiprazole; systemic

4.0

38.1

110

282

WYA30, ,

SPAT

6.8

37.8

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.7

37.6

209

800

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.8

37.2

694

4253

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.3

37.1

227

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

371.1

37.1

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.6

37.0

228

919

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.7

36.8

214

838

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.5

36.2

250

1063

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

36.1

475

2606

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

36.1

322

1530

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

5.3

36.0

137

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.1

36.0

157

527

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

35.7

345

1691

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

35.4

1394

10319

M54

ICD-10 Finland

Dorsalgia

2.0

34.7

427

2288

N06AX03

ATC

mianserin; oral

2.6

34.7

214

863

R35

ICD-10 Finland

Polyuria

2.2

34.3

312

1494

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.8

34.2

172

625

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

34.1

492

2780

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.6

34.1

821

11840

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.3

33.8

258

1147

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.7

33.8

195

761

N03AX16

ATC

[U] pregabalin

1.6

33.7

888

5958

-1, ,

NOMESCO Finland

1.6

33.2

1007

6990

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.7

33.0

190

740

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

32.8

229

979

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

32.7

810

5345

RS222, ,

NOMESCO Finland

4.6

32.4

170

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

32.4

1725

13558

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

32.3

2211

18314

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

32.2

402

2162

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.2

32.0

205

EB1HA, ,

SPAT

3.9

31.9

254

K02.1

ICD-10 Finland

Caries of dentine

1.5

31.8

1754

13864

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

31.8

1448

10995

N05CF01

ATC

zopiclone; oral

1.5

31.7

1258

9270

N02BE01

ATC

paracetamol; systemic, rectal

1.8

31.7

3172

28677

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

31.6

626

3887

N06AB03

ATC

fluoxetine; oral

1.9

31.4

434

2415

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

31.4

242

1081

F00

ICD-10 Finland

Dementia in Alzheimer disease

53.4

31.3

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.2

31.1

278

1321

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.2

30.8

127

412

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.5

30.8

173

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.3

30.8

119

SPAT1249

SPAT

Treatment-related counselling outside office

0.6

30.5

710

10397

D12

ICPC

Constipation

2.6

30.4

175

682

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.6

30.3

785

5225

D11

ICPC

Diarrhoea

2.0

30.3

377

2025

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.2

30.1

193

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

29.8

469

2717

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

29.6

586

3630

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

29.6

129

433

H81

ICPC

Excessive ear wax

1.6

29.5

742

4900

GD1LA

NOMESCO Finland

3.7

29.4

264

N03AF01

ATC

carbamazepine; oral, rectal

2.4

29.4

217

951

J01DB01

ATC

cefalexin; oral

1.6

29.1

2824

24914

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

29.1

865

5946

C10AA05

ATC

atorvastatin; oral

1.5

29.1

1659

13121

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

29.0

664

4278

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

29.0

264

1263

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

29.0

285

1405

WX212

NOMESCO Finland

Femoral plexus blockade

3.0

28.8

128

434

ZXC20

NOMESCO Finland

Use of chemical agents

3.0

28.6

125

420

XF404

NOMESCO Finland

Ambulatory ECG

1.9

28.5

392

2176

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

3.0

28.4

125

422

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.9

28.3

128

M54.5

ICD-10 Finland

Low back pain

1.5

28.1

1181

8756

SPAT1153

SPAT

Removal of sutures

0.6

27.8

613

9149

J45

ICD-10 Finland

Asthma

1.9

27.7

362

1975

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.6

27.6

161

632

S01.0

ICD-10 Finland

Open wound of scalp

2.0

27.5

307

1585

WYA10

NOMESCO Finland

Emergency care or similar visit

2.2

27.5

252

1208

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

27.3

1183

8815

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.3

27.2

105

328

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

27.1

942

6694

S22.3

ICD-10 Finland

Fracture of rib

2.1

27.1

280

1406

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

75.7

26.8

R52.9

ICD-10 Finland

Pain, unspecified

1.9

26.6

361

1992

A06AD11

ATC

lactulose; oral

1.7

26.6

624

4038

L84

ICD-10 Finland

Corns and callosities

2.6

26.5

161

644

M02AA07

ATC

piroxicam; topical

1.5

26.4

1350

10388

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.8

26.4

139

518

UJH02

NOMESCO Finland

Anoscopy

2.5

26.3

173

719

S16

ICPC

Bruise/contusion

2.6

26.2

154

606

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

26.0

535

3342

N05CD07

ATC

temazepam; oral

1.7

25.8

511

3157

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

5.6

25.8

G04BD12

ATC

mirabegron; oral

1.7

25.7

499

3067

N06AX12

ATC

bupropion; oral

2.5

25.7

160

648

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.0

25.7

190

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.8

25.6

132

486

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

5.2

25.5

101

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.4

25.5

180

773

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.8

25.4

N05CF02

ATC

zolpidem; oral

1.7

25.2

579

3723

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.6

25.0

130

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

24.8

680

4565

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.8

24.8

204

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

130.9

24.6

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

24.4

783

5447

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

24.4

1103

8253

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.9

24.2

116

411

L17

ICPC

Foot/toe symptom/complaint

1.5

24.2

1017

7495

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

24.1

218

1039

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

23.9

1604

12915

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.3

23.9

287

SFA10

NOMESCO Finland

One-surface restoration

1.4

23.9

1644

13300

SPAT1312

SPAT

General health counselling

0.6

23.6

532

7959

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

41.7

23.6

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.2

23.6

205

962

G40

ICD-10 Finland

Epilepsy

5.6

23.5

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

23.4

206

972

F61.0

ICD-10 Finland

Mixed personality disorders

4.7

23.4

113

H02AB07

ATC

prednisone; oral

1.7

23.3

526

3360

SPAT1325

SPAT

Vaccination

0.6

23.3

732

10174

A02BC02

ATC

pantoprazole; systemic

1.4

23.3

2407

20906

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

23.1

653

4407

A01

ICPC

Pain general/multiple sites

1.8

23.1

345

1962

R83

ICPC

Respiratory infection other

1.6

22.9

587

3871

L28

ICPC

Limited function/disability (L)

1.6

22.9

716

4947

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.6

22.8

526

7840

ZXA10

NOMESCO Finland

Bilateral

1.5

22.8

734

5102

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.0

22.8

241

1219

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

22.8

177

793

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

22.7

1744

14339

XA400

NOMESCO Finland

EEG

6.4

22.6

X57

ICD-10 Finland

Unspecified privation

3.0

22.5

100

340

R60.0

ICD-10 Finland

Localized oedema

1.7

22.4

502

3199

S18

ICPC

Laceration/cut

1.4

22.3

1639

13354

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

22.3

176

793

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

22.2

196

925

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.6

22.2

135

541

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

7.3

22.0

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

22.0

281

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.4

22.0

149

628

J01FA06

ATC

roxithromycin; oral

1.4

22.0

1337

10531

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

21.9

174

786

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

5.5

21.9

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

21.9

639

4340

C10AA01

ATC

simvastatin; oral

1.4

21.9

1748

14433

J01MA02

ATC

ciprofloxacin; systemic

1.4

21.9

1409

11209

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

21.9

375

2221

A02BC05

ATC

esomeprazole; systemic

1.4

21.8

1393

11060

SFA20

NOMESCO Finland

Two-surface restoration

1.4

21.8

1679

13776

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

21.7

571

3784

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

21.7

393

2363

N05AN01

ATC

lithium; oral

3.5

21.6

219

N02AX02

ATC

tramadol; systemic, rectal

1.4

21.6

1532

12383

R51

ICD-10 Finland

Headache

2.3

21.6

168

753

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.8

21.4

169

WX320

NOMESCO Finland

Spinalanesthesy

1.5

21.4

888

6501

N05BE01

ATC

buspirone; oral

2.9

21.3

101

356

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

21.3

274

1484

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

4.2

21.1

131

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

8.5

21.0

R01AD09

ATC

mometasone; nasal

1.4

21.0

1318

10415

N03AE01

ATC

clonazepam; systemic

2.1

21.0

203

993

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

20.9

158

699

WX290, ,

SPAT

2.8

20.9

107

393

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

16.6

20.9

G44.2

ICD-10 Finland

Tension-type headache

1.7

20.8

424

2632

XF402

NOMESCO Finland

ECG with work load test

1.7

20.8

436

2727

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.6

20.8

545

7919

U02

ICPC

Urinary frequency/urgency

1.6

20.8

522

3418

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

20.8

378

2275

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

20.8

512

3338

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.9

20.7

155

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.6

20.7

192

ZXD05

NOMESCO Finland

Urgent procedure

1.4

20.6

1032

7822

WW200, ,

SPAT

0.6

20.6

326

5359

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

20.5

596

4040

S01

ICD-10 Finland

Open wound of head

3.9

20.4

152

M01AB05

ATC

diclofenac; systemic, rectal

1.4

20.4

2123

18237

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.6

20.4

118

462

R05

ICD-10 Finland

Cough

1.5

20.3

719

5087

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

2.3

20.1

159

717

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

20.1

1215

9517

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

20.1

1292

10229

SFA30

NOMESCO Finland

Three-surface restoration

1.4

20.0

1257

9916

R06.0

ICD-10 Finland

Dyspnoea

1.4

20.0

1030

7843

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.4

19.9

112

F32.8

ICD-10 Finland

Other depressive episodes

4.0

19.8

142

J20

ICD-10 Finland

Acute bronchitis

1.8

19.7

343

2038

Y94.8

ICD-10 Finland

Other leisure activity accident

2.7

19.7

109

417

Z01.2

ICD-10 Finland

Dental examination

1.4

19.4

1292

10278

N06AG02

ATC

moclobemide; oral

2.2

19.3

157

717

EBA30

NOMESCO Finland

Extraction of root of tooth

2.0

19.3

215

1108

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.1

19.3

ZY010

NOMESCO Finland

Hospital outpatient

2.4

19.3

138

597

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.7

18.9

161

183

Kela drug reimbursment

Lamotrigin and topiramate

5.8

18.8

F0019, G301,

ICD-10 Finland

+∞

18.8

F009, G309,

ICD-10 Finland

+∞

18.8

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

3.5

18.6

186

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

18.6

218

1143

P29

ICPC

Psychological sympt/compl other

2.2

18.5

153

703

G20

ICD-10 Finland

Parkinson disease

2.4

18.5

127

539

J01DA06

ATC

[U] cefuroxime

1.6

18.4

465

3044

N06AB05

ATC

paroxetine; oral

2.1

18.1

173

842

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

18.1

414

2644

VALMI, ,

NOMESCO Finland

1.5

18.1

678

4841

N03AX12

ATC

[U] gabapentin; oral

1.5

18.1

569

3916

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

17.9

734

5333

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

17.9

451

2949

AA40B, ,

NOMESCO Finland

6.5

17.9

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.2

17.9

144

655

G04CA02

ATC

tamsulosin; oral

1.4

17.9

891

6719

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

7.6

17.8

R07.3

ICD-10 Finland

Other chest pain

1.7

17.8

372

2323

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

17.8

390

2466

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

17.6

624

4402

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

17.6

426

2759

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

17.5

234

1282

B01AC04

ATC

clopidogrel; oral

1.5

17.5

697

5034

C07AA05

ATC

propranolol; systemic

1.5

17.5

579

4027

PA6AD

NOMESCO Finland

CT of neck arteries

2.4

17.3

123

530

XCK20, ,

NOMESCO Finland

5.4

17.3

SPAT1360

SPAT

Extensive global examination

1.8

17.3

252

1420

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

17.3

606

4266

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

17.3

1264

10164

G04BD08

ATC

solifenacin; oral

1.8

17.2

274

1587

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

17.1

1442

11847

R03BA02

ATC

budesonide; inhalant

1.5

17.1

566

3934

RS221, ,

NOMESCO Finland

3.4

17.1

182

XX1VW, ,

SPAT

4.5

17.0

F22.0

ICD-10 Finland

Delusional disorder

3.7

17.0

149

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

17.0

957

7362

K08.3

ICD-10 Finland

Retained dental root

1.8

17.0

264

1516

E0000UV, ,

ATC

1.4

17.0

1314

10652

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

16.9

322

1959

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.5

16.8

160

J01EA01

ATC

trimethoprim; systemic

1.4

16.7

906

6920

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

0.6

16.7

372

5645

S06.2

ICD-10 Finland

Diffuse brain injury

4.3

16.7

102

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.9

16.6

P76

ICPC

Depressive disorder

2.1

16.6

151

722

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

2.2

16.6

144

676

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

16.6

633

4530

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

16.4

16.5

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.9

16.5

259

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

16.5

241

1359

K59.01

ICD-10 Finland

Constipation outlet obstruction type

3.5

16.5

162

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

16.4

1245

10050

H02AA02

ATC

fludrocortisone; oral

4.4

16.3

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

16.3

1891

16260

SDA03

NOMESCO Finland

Periodontal treatment

1.4

16.3

1092

8638

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.7

16.3

474

6790

G50.1

ICD-10 Finland

Atypical facial pain

3.1

16.3

229

S20.2

ICD-10 Finland

Contusion of thorax

2.0

16.2

177

906

N03AX18

ATC

lacosamide; systemic

5.8

16.2

F80.1

ICD-10 Finland

Expressive language disorder

4.5

16.1

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

16.1

897

6880

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

16.1

197

1050

D01

ICPC

Abdominal pain/cramps general

1.6

16.0

355

2247

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

16.0

170

S70.0

ICD-10 Finland

Contusion of hip

2.1

16.0

152

740

SPAT1310

SPAT

Counselling related to known health issue

0.7

15.9

614

8331

G40.10

ICD-10 Finland

Simple partial seizures

4.8

15.9

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.4

15.9

R13

ICD-10 Finland

Dysphagia

1.8

15.9

260

1517

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

15.8

166

839

S09.9

ICD-10 Finland

Unspecified injury of head

3.1

15.7

218

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

15.7

816

6180

F05.8

ICD-10 Finland

Other delirium

4.4

15.7

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

15.6

919

7105

G47.3

ICD-10 Finland

Sleep apnoea

1.5

15.6

657

4785

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.8

15.6

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.1

15.6

103

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.4

15.5

108

462

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

15.4

218

1216

X58

ICD-10 Finland

Exposure to other specified factors

1.6

15.4

401

2639

R52.0

ICD-10 Finland

Acute pain

2.3

15.3

110

477

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.7

15.3

127

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.0

15.3

163

828

R1250

NOMESCO Finland

Evaluation of functional capability

2.8

15.3

265

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

5.9

15.2

M79.1

ICD-10 Finland

Myalgia

1.6

15.2

416

2770

R74

ICPC

Upper respiratory infection acute

1.4

15.2

734

5482

EBA30, ,

SPAT

4.9

15.2

N01

ICPC

Headache

1.7

15.1

266

1583

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

5.3

15.1

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.2

15.0

129

603

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.1

15.0

102

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

15.0

1549

13043

RK520, ,

NOMESCO Finland

5.4

14.9

RK120, ,

NOMESCO Finland

6.5

14.9

N05BA12

ATC

alprazolam; oral

1.7

14.8

314

1966

RS220, ,

NOMESCO Finland

3.4

14.8

154

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.7

14.8

298

G04CB01

ATC

finasteride; oral

1.5

14.7

438

2970

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.8

14.6

249

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

14.5

359

2333

R25.1

ICD-10 Finland

Tremor, unspecified

2.2

14.5

123

572

U07

ICPC

Urine symptom/complaint other

1.7

14.5

275

1671

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

14.5

620

4526

B01AB04

ATC

dalteparin; parenteral

1.8

14.4

201

1117

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.2

14.4

R05

ICPC

Cough

1.4

14.4

749

5663

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

14.4

2892

26731

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

5.5

14.3

N03AX11

ATC

topiramate; oral

3.0

14.3

209

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.5

14.2

AA400

NOMESCO Finland

Electroconvulsive therapy

4.7

14.2

N05AB03

ATC

perphenazine; systemic, rectal

2.3

14.2

105

462

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

2.3

14.2

104

456

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.3

14.1

108

482

L01

ICPC

Neck symptom/complaint

1.5

14.1

461

3190

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

14.1

200

R11

ICD-10 Finland

Nausea and vomiting

1.7

14.1

285

1763

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

13.9

252

1512

R15

ICD-10 Finland

Faecal incontinence

2.1

13.9

125

596

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

13.9

1255

10334

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

13.9

418

2842

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

13.9

660

4909

P03

ICPC

Feeling depressed

1.8

13.9

206

1168

Z00.8

ICD-10 Finland

Other general examinations

1.7

13.8

238

1408

L03

ICPC

Low back symptom/complaint

1.4

13.8

854

6638

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

13.8

159

830

B35.1

ICD-10 Finland

Tinea unguium

1.8

13.8

200

1125

XCH05

NOMESCO Finland

Eye pressure longterm registration

3.3

13.8

151

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

13.8

613

4503

K44

ICD-10 Finland

Diaphragmatic hernia

3.7

13.7

118

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.2

13.7

118

553

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

13.7

127

613

WX402

NOMESCO Finland

General anaesthesia

1.4

13.7

610

4484

RK290, ,

NOMESCO Finland

6.5

13.6

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

13.6

112

515

R06AE07

ATC

cetirizine; oral

1.3

13.6

1282

10608

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

12.1

13.6

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

13.5

262

1602

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

13.5

517

3691

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.6

13.5

124

M54.8

ICD-10 Finland

Other dorsalgia

2.0

13.4

144

733

J01MA06

ATC

norfloxacin; oral

1.5

13.4

451

3137

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.5

13.4

343

C07AB07

ATC

bisoprolol; oral

1.3

13.4

1890

16510

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

13.3

178

976

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

13.3

359

2380

M03BX02

ATC

tizanidine; oral

1.3

13.3

1799

15620

N06AB08

ATC

fluvoxamine; oral

2.4

13.3

387

B01AB05

ATC

enoxaparin; parenteral

1.3

13.3

1106

8986

J01AA02

ATC

doxycycline; systemic

1.3

13.2

2605

23786

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

13.2

152

793

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

13.2

438

S01.8

ICD-10 Finland

Open wound of other parts of head

3.1

13.2

176

R1260

NOMESCO Finland

Evaluation of communicative skills

2.7

13.2

275

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

13.1

200

1142

S72.0

ICD-10 Finland

Fracture of neck of femur

1.9

13.1

162

866

P01AB01

ATC

metronidazole; oral, rectal

1.3

13.1

1198

9858

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

13.1

617

4576

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

13.1

690

5218

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

12.2

13.1

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

13.1

117

557

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.2

13.1

108

498

S06.3

ICD-10 Finland

Focal brain injury

3.2

13.0

157

N06AA09

ATC

amitriptyline; systemic

1.6

13.0

340

2240

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

13.0

288

1824

M79.7

ICD-10 Finland

Fibromyalgia

2.3

12.9

424

HMAK, ,

NOMESCO Finland

0.5

12.9

103

2105

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

12.9

109

508

J01CA04

ATC

amoxicillin; systemic

1.3

12.8

2602

23794

RK110, ,

NOMESCO Finland

3.7

12.8

105

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

12.8

112

529

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

12.7

145

755

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

12.7

491

3512

SPAT1263

SPAT

Sampling

0.7

12.6

921

11356

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

3.0

12.6

186

F06.0

ICD-10 Finland

Organic hallucinosis

12.3

12.6

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

6.0

12.6

R23

ICD-10 Finland

Other skin changes

3.3

12.6

145

N05AD01

ATC

haloperidol; systemic

2.3

12.6

435

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

12.5

151

802

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

12.5

103

475

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

4.2

12.4

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.0

12.4

N05AL01

ATC

sulpiride; systemic

3.0

12.4

188

J01DA01

ATC

[U] cefalexin

1.3

12.4

1986

17561

R2110

NOMESCO Finland

Giving the first information

1.8

12.3

188

1074

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

12.3

384

2627

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

12.3

2040

18104

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

12.3

593

4411

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

3.0

12.3

178

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

12.2

224

1349

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.2

12.2

101

466

R31

ICD-10 Finland

Unspecified haematuria

1.5

12.2

381

2608

N05AA02

ATC

levomepromazine; systemic

2.1

12.2

119

586

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

12.2

797

6233

R73

ICD-10 Finland

Elevated blood glucose level

2.1

12.1

111

534

D10

ICPC

Vomiting

2.1

12.1

116

568

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

2.2

12.0

424

R33

ICD-10 Finland

Retention of urine

1.6

12.0

300

1954

G04BD11

ATC

fesoterodine; oral

2.1

12.0

117

576

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

11.9

411

2870

EBA05, ,

SPAT

2.7

11.9

231

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.1

11.9

155

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.3

11.9

N06AA06

ATC

trimipramine; systemic

2.4

11.9

357

P99

ICPC

Psychological disorders other

2.6

11.8

267

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

14.7

11.8

J01FA10

ATC

azithromycin; systemic

1.3

11.7

1585

13678

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

0.6

11.7

285

4270

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

11.7

2319

20986

N05AF03

ATC

chlorprothixene; systemic

2.5

11.7

292

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

11.7

261

1656

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

11.6

111

542

Z04

ICD-10 Finland

Examination and observation for other reasons

2.6

11.6

263

J02AC01

ATC

fluconazole; systemic

1.3

11.6

1063

8721

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

11.5

186

1081

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.9

11.5

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

11.5

240

1497

RS210, ,

NOMESCO Finland

5.7

11.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

11.5

545

4042

F01.1

ICD-10 Finland

Multi-infarct dementia

+∞

11.5

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

11.5

Z02

ICD-10 Finland

Examination and encounter for administrative purposes

4.0

11.5

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

11.4

398

2785

N88

ICPC

Epilepsy

4.8

11.4

A02BC03

ATC

lansoprazole; oral

1.3

11.4

980

7965

J01CA08

ATC

pivmecillinam; oral

1.3

11.4

1230

10306

R01AD08

ATC

fluticasone; nasal

1.3

11.4

773

6073

WX780

NOMESCO Finland

Remote monitoring CPAP

2.0

11.4

116

581

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.9

11.4

181

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

2.9

11.4

181

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

11.4

274

1770

N39

ICD-10 Finland

Other disorders of urinary system

3.4

11.4

119

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

2.8

11.3

209

R30.0

ICD-10 Finland

Dysuria

1.9

11.2

130

681

Z01

ICD-10 Finland

Other special examinations and investigations of persons without complaint or reported diagnosis

4.1

11.1

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.7

11.1

R21

ICPC

Throat symptom/complaint

1.4

11.1

453

3269

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.4

11.1

1179

U04

ICPC

Incontinence urine

1.7

11.1

197

1178

WX290

NOMESCO Finland

Other blockage of nerve

1.3

11.0

1131

9406

L60.3

ICD-10 Finland

Nail dystrophy

4.4

11.0

A02BC01

ATC

omeprazole; systemic

1.3

11.0

939

7622

ZA1.0

ICD-10 Finland

Shoulder region

2.2

10.9

396

N28

ICPC

Limited function/disability (N)

2.7

10.9

219

F51

ICD-10 Finland

Nonorganic sleep disorders

2.2

10.9

410

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

10.8

516

3826

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.2

10.8

404

F01

ICD-10 Finland

Vascular dementia

11.9

10.8

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.6

10.8

225

1402

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

10.7

233

1467

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.6

10.7

S00.0

ICD-10 Finland

Superficial injury of scalp

2.2

10.7

374

R03AC02

ATC

salbutamol; inhalant

1.3

10.7

1670

14612

N02AA05

ATC

oxycodone; systemic

1.4

10.6

640

4930

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.9

10.6

172

UJF32

NOMESCO Finland

Coloscopy

1.3

10.6

911

7396

N07BB01

ATC

disulfiram; oral

2.1

10.5

475

H02.4

ICD-10 Finland

Ptosis of eyelid

2.0

10.5

107

536

P74

ICPC

Anxiety disorder/anxiety state

2.2

10.5

416

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.3

10.5

352

R02

ICPC

Shortness of breath/dyspnoea

1.4

10.4

457

3339

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

3.4

10.4

106

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

10.4

204

1252

I63

ICD-10 Finland

Cerebral infarction

3.3

10.4

116

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

10.4

182

1084

G04BD07

ATC

tolterodine; oral

1.7

10.4

192

1161

RS121, ,

NOMESCO Finland

4.2

10.3

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

10.3

382

2705

L70.2

ICD-10 Finland

Acne varioliformis

5.1

10.3

ZQZ00

NOMESCO Finland

Treatment of several skin areas

3.5

10.3

102

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

10.3

761

6045

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

3.4

10.3

107

Z25

ICPC

Assault/harmful event problem

4.9

10.3

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

10.2

301

2034

UJD10, ,

SPAT

2.2

10.2

356

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.6

10.2

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.8

10.2

187

130

Kela drug reimbursment

Malignant tumour

0.6

10.2

139

2402

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

10.2

228

1448

RK320, ,

NOMESCO Finland

3.2

10.1

123

E03

ICD-10 Finland

Other hypothyroidism

1.7

10.1

182

1092

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

10.1

243

1569

F32.0

ICD-10 Finland

Mild depressive episode

2.4

10.1

264

SPAT1262

SPAT

Handing over of treatment supplies

0.7

10.1

318

4525

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.4

10.1

1449

F29

ICPC

Eye symptom/complaint other

1.5

10.0

275

1829

XX9XW, ,

NOMESCO Finland

4.3

10.0

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

10.0

362

2550

A02BA02

ATC

ranitidine; systemic

1.3

10.0

680

5331

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

10.0

1234

10472

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

10.0

196

1203

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

4.8

10.0

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

10.0

210

1312

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

10.0

247

N06AX18

ATC

reboxetine; oral

3.2

10.0

124

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.9

10.0

125

673

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

10.0

267

1767

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

10.0

215

1352

J01FA01

ATC

erythromycin; systemic

1.5

10.0

336

2335

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

40.2

10.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

10.0

322

2219

J01FA09

ATC

clarithromycin; systemic

1.3

10.0

857

6947

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

4.1

9.9

I50

ICD-10 Finland

Heart failure

1.8

9.9

150

856

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

4.1

9.9

H01

ICPC

Ear pain/earache

1.5

9.9

289

1951

S80.0

ICD-10 Finland

Contusion of knee

1.7

9.9

194

1192

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.9

9.8

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

5.2

9.8

K05.1

ICD-10 Finland

Chronic gingivitis

1.7

9.8

173

1033

R06.5

ICD-10 Finland

Mouth breathing

1.6

9.8

239

1549

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

9.8

226

1446

R44.3

ICD-10 Finland

Hallucinations, unspecified

4.5

9.8

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

9.8

108

558

H02AB02

ATC

dexamethasone; systemic

0.6

9.8

164

2683

EBA00

NOMESCO Finland

Extraction of tooth

1.3

9.7

997

8267

L30

ICD-10 Finland

Other dermatitis

2.3

9.7

300

J04.0

ICD-10 Finland

Acute laryngitis

2.2

9.7

364

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

9.7

316

2183

L60.0

ICD-10 Finland

Ingrowing nail

1.8

9.6

143

812

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

55.1

9.6

L04

ICPC

Chest symptom/complaint

1.7

9.6

191

1176

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.9

9.6

116

617

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.2

9.6

R03DC03

ATC

montelukast; oral

1.4

9.6

436

3204

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

9.6

411

2989

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.9

9.6

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

9.6

147

844

L12

ICPC

Hand/finger symptom/complaint

1.4

9.5

459

3406

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

4.8

9.5

K30

ICD-10 Finland

Functional dyspepsia

1.5

9.4

327

2285

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.2

9.4

113

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.8

9.4

172

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

9.4

373

2673

D01AE16

ATC

amorolfine; topical

1.4

9.4

396

2871

Y94.0

ICD-10 Finland

Accident at home

2.3

9.4

317

R25.2

ICD-10 Finland

Cramp and spasm

2.2

9.4

369

A07DA03

ATC

loperamide; oral

1.9

9.4

121

659

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.7

9.3

190

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.7

9.3

173

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.4

9.3

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.8

9.3

D01AC02

ATC

miconazole; topical

1.5

9.3

254

1689

A97

ICPC

No disease

1.4

9.2

555

4268

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

9.2

431

T74.1

ICD-10 Finland

Physical abuse

3.1

9.2

125

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.2

1032

8637

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

1.8

9.2

124

684

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

9.2

229

1491

J01FF01

ATC

clindamycin; systemic

1.3

9.2

818

6650

R00.2

ICD-10 Finland

Palpitations

1.6

9.2

213

1364

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.7

9.2

171

1036

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.2

9.2

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.7

9.1

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.1

9.1

406

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

9.1

221

1430

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.9

9.1

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.5

9.1

234

R52.2

ICD-10 Finland

Other chronic pain

1.9

9.1

113

608

R06.4

ICD-10 Finland

Hyperventilation

2.7

9.1

170

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

9.1

391

2846

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

9.1

877

7206

N06AA10

ATC

nortriptyline; systemic

2.3

9.0

278

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.2

9.0

316

UKC02

NOMESCO Finland

Cystoscopy

1.3

9.0

577

4481

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.8

9.0

640

7994

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.5

8.9

218

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

8.9

398

2914

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.7

8.9

D07AA02

ATC

hydrocortisone; topical

1.4

8.8

371

2688

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

8.8

128

723

G46.7*I67.9

ICD-10 Finland

Other lacunar syndromes

10.7

8.8

P01

ICPC

Feeling anxious/nervous/tense

1.6

8.7

199

1269

SAA01, ,

SPAT

3.2

8.7

103

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

8.7

640

5064

WYA20

NOMESCO Finland

Home visit

2.5

8.7

209

D64.8

ICD-10 Finland

Other specified anaemias

2.1

8.7

354

R4150

NOMESCO Finland

Neuropsychological rehabilitation

3.9

8.7

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

50.1

8.7

F01.8

ICD-10 Finland

Other vascular dementia

50.1

8.7

A01AB09

ATC

miconazole; local oral

1.5

8.6

287

1990

A06AC51

ATC

ispaghula, combinations; oral

1.7

8.6

156

939

UJF30, ,

SPAT

2.9

8.6

136

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

8.6

128

730

AP1

Catheterization of the left side of the heart

2.2

8.5

331

I11

ICD-10 Finland

Hypertensive heart disease

3.2

8.5

105

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.6

8.5

174

1082

WX872

NOMESCO Finland

Intensive care

1.6

8.5

170

1051

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.9

8.5

515

C09AA05

ATC

ramipril; oral

1.3

8.5

951

7949

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

8.5

157

951

M01AE02

ATC

naproxen; oral, rectal

1.2

8.5

1635

14509

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

8.5

343

2469

I67.4

ICD-10 Finland

Hypertensive encephalopathy

20.1

8.5

U01

ICPC

Dysuria/painful urination

1.5

8.5

235

1569

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

8.4

255

1733

H53.2

ICD-10 Finland

Diplopia

1.9

8.4

107

580

M01AX05

ATC

glucosamine; oral

1.3

8.4

753

6119

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

8.4

241

1620

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

8.4

120

675

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

8.4

169

1046

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.6

8.4

120

2047

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.6

8.4

176

1101

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

2.5

8.4

201

H92.0

ICD-10 Finland

Otalgia

1.7

8.4

151

908

H91.1

ICD-10 Finland

Presbycusis

1.5

8.4

282

1960

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

8.4

560

4373

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

4.5

8.4

Z29.8

ICD-10 Finland

Other specified prophylactic measures

2.1

8.3

340

XKD00

NOMESCO Finland

Uroflowmetry

1.3

8.3

549

4277

I67.2

ICD-10 Finland

Cerebral atherosclerosis

4.0

8.3

H57.1

ICD-10 Finland

Ocular pain

1.9

8.3

519

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

10.8

8.3

U05

ICPC

Urination problems other

1.6

8.2

179

1129

M54.2

ICD-10 Finland

Cervicalgia

1.5

8.2

219

1448

M19

ICD-10 Finland

Other arthrosis

2.0

8.2

457

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

3.1

8.2

107

D09

ICPC

Nausea

1.8

8.2

113

628

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.4

8.2

215

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.1

8.2

329

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.5

8.2

203

P15

ICPC

Chronic alcohol abuse

2.2

8.2

303

Z48.8

ICD-10 Finland

Other specified surgical follow-up care

3.4

8.2

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

8.2

240

1621

R44.1

ICD-10 Finland

Visual hallucinations

4.2

8.2

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.6

8.2

168

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.1

8.2

356

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

8.2

194

1250

SPAT1149

SPAT

Suture or treatment of traumatic wound

0.7

8.2

214

3166

H53.4

ICD-10 Finland

Visual field defects

2.1

8.1

350

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.3

8.1

253

G41.9

ICD-10 Finland

Status epilepticus, unspecified

3.9

8.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

0.7

8.1

245

3524

N06AX17

ATC

milnacipran; oral

3.1

8.1

108

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.0

8.1

391

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.1

8.1

331

K57

ICD-10 Finland

Diverticular disease of intestine

2.0

8.1

385

H03AA01

ATC

levothyroxine sodium; systemic

1.3

8.0

714

5794

N06AX05

ATC

trazodone; oral

2.1

8.0

326

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

8.0

483

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

8.0

242

1646

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

2.9

8.0

120

G43.3

ICD-10 Finland

Complicated migraine

3.0

7.9

115

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.0

7.9

388

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

7.9

368

2714

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.9

7.9

528

S29

ICPC

Skin symptom/complaint other

1.3

7.9

596

4733

S22

ICPC

Nail symptom/complaint

1.6

7.9

193

1254

R26

ICD-10 Finland

Abnormalities of gait and mobility

7.8

7.9

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

7.9

360

2648

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

7.9

341

2485

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

7.8

396

2960

ZX080

NOMESCO Finland

Image guided radiotherapy

0.2

7.8

386

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

4.1

7.8

S00

ICD-10 Finland

Superficial injury of head

3.4

7.8

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

0.6

7.8

111

1895

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.1

7.8

357

H60

ICD-10 Finland

Otitis externa

1.7

7.7

125

730

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

7.7

315

2270

N06BA04

ATC

methylphenidate; oral

2.7

7.7

150

ZY000

NOMESCO Finland

Hospital inpatient

3.0

7.7

106

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

7.7

252

1741

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

45.1

7.7

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.3

7.7

247

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.4

7.7

222

D07AC01

ATC

betamethasone; topical

1.2

7.7

1093

9366

R12

ICD-10 Finland

Heartburn

1.5

7.7

222

1496

AAF15

NOMESCO Finland

Ventriculoatrial shunt

5.9

7.7

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.4

7.7

210

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

3.4

7.7

F31

ICD-10 Finland

Bipolar affective disorder

3.4

7.7

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.2

7.7

K07.60

ICD-10 Finland

Snapping jaw

1.8

7.6

107

599

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.7

7.6

129

763

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

7.6

225

1524

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.9

7.6

118

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

2.8

7.6

129

M15

ICD-10 Finland

Polyarthrosis

1.6

7.6

188

1225

SPAT1211

SPAT

Application of soft bandage

0.6

7.6

122

2017

R06AX27

ATC

desloratadine; oral

1.3

7.6

667

5403

S01KA02

ATC

hypromellose; ophthalmic

2.1

7.6

327

XCK00

NOMESCO Finland

Perimetry

1.5

7.6

221

1493

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

7.6

125

735

SAA04

NOMESCO Finland

Special examination of mouth

1.7

7.5

141

857

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.2

7.5

262

N05AH02

ATC

clozapine; systemic

2.8

7.5

124

D01BA02

ATC

terbinafine; oral

1.3

7.5

769

6347

ZXC60

NOMESCO Finland

Application of heat

2.5

7.5

182

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

7.5

424

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

7.5

291

2081

R06AX22

ATC

ebastine; oral

1.4

7.4

416

3160

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

7.4

524

J01CF05

ATC

flucloxacillin; systemic

1.6

7.4

174

1119

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

3.9

7.4

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

80.3

7.4

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

7.4

237

1631

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.9

7.4

482

I70

ICD-10 Finland

Atherosclerosis

3.4

7.4

Z43.5

ICD-10 Finland

Attention to cystostomy

3.4

7.4

T78.4

ICD-10 Finland

Allergy, unspecified

1.8

7.4

105

591

S14

ICPC

Burn/scald

1.9

7.4

497

L03

ICD-10 Finland

Cellulitis

2.9

7.4

120

K02.2

ICD-10 Finland

Caries of cementum

1.6

7.3

146

903

H25.9

ICD-10 Finland

Senile cataract, unspecified

2.0

7.3

345

F0029, G308,

ICD-10 Finland

+∞

7.3

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

+∞

7.3

F00, F03,

ICD-10 Finland

+∞

7.3

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

7.3

298

2149

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.2

7.3

253

P80

ICPC

Personality disorder

6.8

7.3

R52.1

ICD-10 Finland

Chronic intractable pain

3.1

7.3

N02CC04

ATC

rizatriptan; oral

1.8

7.3

550

RL210, ,

NOMESCO Finland

4.1

7.3

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.4

7.3

203

F33

ICD-10 Finland

Recurrent depressive disorder

2.6

7.3

161

H25.8

ICD-10 Finland

Other senile cataract

0.7

7.2

253

3541

Z72.1

ICD-10 Finland

Alcohol use

3.0

7.2

105

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

4.3

7.2

R47.0

ICD-10 Finland

Dysphasia and aphasia

2.6

7.2

150

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.0

7.2

100

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

3.0

7.2

100

Z72.2

ICD-10 Finland

Drug use

7.3

7.2

F41

ICD-10 Finland

Other anxiety disorders

2.8

7.2

122

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.8

7.2

122

M02AA15

ATC

diclofenac; topical

1.5

7.1

233

1610

N02BF02

ATC

pregabalin; oral

1.6

7.1

164

1050

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.6

7.1

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

2.0

7.1

362

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.2

7.1

262

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

7.1

195

1300

WX704

NOMESCO Finland

Intubation

1.5

7.1

225

1546

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.8

7.1

117

N27

ICPC

Fear of neurological disease other

2.2

7.1

256

I20.09

ICD-10 Finland

Unstable angina

1.5

7.1

215

1465

A01AB04

ATC

amphotericin B; local oral

1.6

7.1

167

1077

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

8.8

7.0

L05

ICPC

Flank/axilla symptom/complaint

1.5

7.0

182

1198

M48.0

ICD-10 Finland

Spinal stenosis

1.3

7.0

448

3471

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

7.0

231

1600

K08.80

ICD-10 Finland

Toothache NOS

1.5

7.0

191

1272

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.2

7.0

271

K03.66

ICD-10 Finland

Tooth plaque

1.5

7.0

195

1306

G40.89

ICD-10 Finland

Other epilepsy

4.4

7.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

6.9

118

700

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

2.3

6.9

220

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.4

6.9

189

SGC10

NOMESCO Finland

Pulp capping

1.6

6.9

168

1090

R54

ICD-10 Finland

Senility

3.7

6.9

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.7

6.9

118

701

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

5.8

6.9

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.7

6.9

136

F44.0

ICD-10 Finland

Dissociative amnesia

13.8

6.9

R03BA01

ATC

beclometasone; inhalant

1.3

6.9

420

3233

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.2

6.9

253

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

2.0

6.9

326

SPF40

NOMESCO Finland

Removal and reattachment of crown or small bridge

2.0

6.9

333

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.4

6.8

913

F41.00

ICD-10 Finland

Moderate panic disorder

2.9

6.8

103

CL2S4, ,

SPAT

2.5

6.8

154

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

1.9

6.8

389

H10

ICD-10 Finland

Conjunctivitis

1.6

6.8

159

1023

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.9

6.8

109

S50.0

ICD-10 Finland

Contusion of elbow

2.0

6.8

362

N03AX23

ATC

brivaracetam; systemic

9.3

6.8

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

2.6

6.8

143

H93.1

ICD-10 Finland

Tinnitus

1.5

6.8

193

1298

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

6.8

342

2557

G04CA01

ATC

alfuzosin; oral

1.3

6.8

399

3056

TNB30

NOMESCO Finland

Soft bandage, upper arm or shoulder

6.1

6.8

WX140

NOMESCO Finland

Parabulbar anesthesy

1.6

6.7

161

1041

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.6

6.7

M01AX01

ATC

nabumetone; oral

1.7

6.7

130

798

S01AA01

ATC

chloramphenicol; ophthalmic

1.6

6.7

144

907

SPAT1148

SPAT

Treatment of chronic ulcer or burn

0.7

6.7

271

3702

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.4

6.7

836

R03DA04

ATC

theophylline; systemic, rectal

1.5

6.7

190

1276

R49.03

ICD-10 Finland

Atrophic dysphonia

2.3

6.7

217

H26.9

ICD-10 Finland

Cataract, unspecified

2.1

6.7

282

P06

ICPC

Sleep disturbance

1.4

6.7

283

2053

S12

ICPC

Insect bite/sting

1.4

6.7

262

1875

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.2

6.7

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

6.7

1051

9076

EMAK, ,

NOMESCO Finland

1.8

6.7

543

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

6.6

393

3011

N04BC05

ATC

pramipexole; oral

1.4

6.6

252

1794

AA1AA

NOMESCO Finland

Head X-ray examination

2.8

6.6

116

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

6.4

6.6

R4190

NOMESCO Finland

Nutritional therapy

1.8

6.6

486

I84

ICD-10 Finland

Hemorrhoids

1.8

6.6

486

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

4.0

6.6

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

6.6

251

1787

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

7.8

6.6

R04.0

ICD-10 Finland

Epistaxis

1.4

6.6

267

1923

N06AA12

ATC

doxepin; systemic

1.6

6.6

163

1063

I83

ICD-10 Finland

Varicose veins of lower extremities

2.0

6.6

366

H53.8

ICD-10 Finland

Other visual disturbances

2.3

6.6

200

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

6.6

139

874

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

6.5

308

2277

A98

ICD-10 Finland

Other viral haemorrhagic fevers, not elsewhere classified

2.2

6.5

239

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

6.5

1220

10711

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

6.5

224

1565

A03FA02

ATC

cisapride; oral, rectal

1.4

6.5

252

1800

N06AA22, ,

ATC

3.0

6.5

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.0

6.5

306

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

6.5

115

691

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

6.5

202

1385

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.7

6.5

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.2

6.4

221

SPAT1043

SPAT

Audiometry

0.7

6.4

204

2907

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.2

6.4

234

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

6.4

160

1045

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

3.5

6.4

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

1.7

6.4

115

693

Z71.1

ICD-10 Finland

Person with feared complaint in whom no diagnosis is made

3.3

6.4

XLA10, ,

NOMESCO Finland

1.7

6.4

108

640

G46.8

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

14.3

6.4

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

6.4

741

6194

B35.3

ICD-10 Finland

Tinea pedis

1.7

6.4

114

687

N05AC01

ATC

periciazine; systemic

4.1

6.3

A46

ICD-10 Finland

Erysipelas

1.3

6.3

483

3834

M01AH05

ATC

etoricoxib; oral

1.2

6.3

1763

16037

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

2.0

6.3

357

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

6.3

130

811

SBB10

NOMESCO Finland

Dental impressions

1.6

6.3

136

858

DAX08

NOMESCO Finland

Fitting of hearing aid

0.6

6.3

1434

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

8.1

6.3

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.0

6.3

330

R03AC03

ATC

terbutaline; inhalant

1.3

6.3

388

2990

G03BB01

ATC

mesterolone; oral

2.9

6.3

TFN04, ,

NOMESCO Finland

2.9

6.3

WZC30

NOMESCO Finland

Teaching

0.7

6.3

284

3809

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

6.3

927

7944

S04

ICPC

Lump/swelling localized

1.4

6.3

283

2076

R5130, ,

SPAT

5.5

6.3

Z87.4

ICD-10 Finland

Personal history of diseases of the genitourinary system

3.5

6.3

101

Kela drug reimbursment

Anterior pituitary hypofunction

3.5

6.3

R01AD05

ATC

budesonide; nasal

1.5

6.3

199

1369

F05

ICPC

Visual disturbance other

1.8

6.3

524

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.5

6.3

155

F0009, G300,

ICD-10 Finland

+∞

6.2

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

6.2

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

+∞

6.2

M19.8

ICD-10 Finland

Other specified arthrosis

1.6

6.2

122

753

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

6.2

176

1183

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.7

6.2

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.8

6.2

497

TNH32

NOMESCO Finland

Custom moulded split, ankle or foot

2.7

6.2

115

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.0

6.2

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

6.2

180

1218

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

6.1

220

1550

N76.0

ICD-10 Finland

Acute vaginitis

1.8

6.1

535

H65

ICD-10 Finland

Nonsuppurative otitis media

3.4

6.1

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.6

6.1

127

N04BC04

ATC

ropinirole; oral

2.6

6.1

127

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.4

6.1

646

U71

ICPC

Cystitis/urinary infection other

1.5

6.1

197

1361

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.7

6.1

110

665

F06.4

ICD-10 Finland

Organic anxiety disorder

12.5

6.1

G43

ICD-10 Finland

Migraine

2.0

6.1

335

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.6

6.1

129

813

X14

ICPC

Vaginal discharge

2.6

6.1

122

AN1

Coronary angiography

1.3

6.0

428

3364

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.8

6.0

493

F98.0

ICD-10 Finland

Nonorganic enuresis

8.6

6.0

ZQX00

NOMESCO Finland

0-4% of the skin

10.0

6.0

F01

ICPC

Eye pain

1.9

6.0

378

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.8

6.0

421

R52

ICD-10 Finland

Pain, not elsewhere classified

2.7

6.0

111

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1569

6071

3.78

307.65

3.6

3.1

2.46

2.47

mmol/l

2.81

1290

5259

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2412

13282

3.41

268.33

2.8

2.1

93.54

94.63

pmol/l

0.54

1231

6719

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

177

19.74

226.73

1.0

41.10

30.79

ng/l

2.33

135

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

177

19.74

226.73

1.0

704.11

853.09

ng/l

1.96

130

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

175

19.50

222.99

1.0

311.37

224.33

ng/l

3.32

137

(3033658) Prothrombin time (PT) actual/Normal

1645

7852

2.99

222.77

4.3

3.9

84.48

85.85

1.22

1591

7658

(3019309) Folate [Moles/volume] in Red Blood Cells

1417

6376

3.00

211.37

1.6

1.7

906.96

1180.80

nmol/l

25.19

902

4718

(3015377) Calcium [Moles/volume] in Serum or Plasma

1965

10699

2.81

202.09

3.0

3.5

2.36

mmol/l

0.32

1649

9204

(3024561) Albumin [Mass/volume] in Serum or Plasma

2310

13880

2.81

192.51

4.6

4.7

35.43

34.69

g/l

8.51

2078

12816

(3021960) Folate [Moles/volume] in Serum or Plasma

1523

7714

2.67

173.82

1.7

1.6

20.57

20.44

nmol/l

0.14

1405

6481

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1360

6570

2.71

169.95

4.4

4.1

198.98

528.17

ng/l

1.60

1194

5561

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1149

5173

2.78

163.96

3.2

3.1

2.50

2.45

e6/l

0.06

547

2889

(3023410) Appearance of Cerebral spinal fluid

189

206

9.62

157.95

1.5

1.4

—

(3003338) MCHC [Mass/volume]

3101

22936

3.35

156.22

30.0

22.0

330.51

331.39

g/l

5.83

3043

22712

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1176

5555

2.65

150.51

3.1

2.9

1.02

1.24

e6/l

1.17

574

3247

(3018418) pH of Serum or Plasma

1711

9679

2.45

148.31

3.4

4.1

7.40

0.25

1905

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

729

2830

2.97

134.34

2.5

2.4

30.99

40.10

u/l

2.87

598

2415

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

252

474

5.64

128.31

1.4

614.90

1235.76

e6/l

0.88

160

387

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

251

473

5.62

127.54

1.3

15.02

32.46

e6/l

0.52

154

364

(3044290) Cell count panel - Cerebral spinal fluid

242

448

5.71

125.31

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

3108

24227

2.91

118.37

28.4

19.7

14.44

15.34

24.19

3045

23741

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

263

554

5.04

117.77

1.2

1.3

446.77

595.91

mg/l

7.10

237

531

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

241

488

5.22

112.89

1.2

3.69

3.87

mmol/l

1.77

208

454

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

836

3801

2.56

111.24

2.0

1.8

—

(36304419) Bacteria [Presence] in Urine

1487

8681

2.20

110.83

3.7

3.2

—

(3030467) Casts [#/volume] in Urine by Automated count

1527

9016

2.19

110.53

3.7

3.3

0.44

0.52

e6/l

0.80

1051

6962

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

835

3819

2.54

109.54

2.1

1.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

289

728

4.23

103.31

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

289

728

4.23

103.31

1.4

1.3

—

(3018095) Leukocytes [#/volume] in Urine

1765

11240

2.11

102.77

4.6

3.8

79.74

120.78

e6/l

2.16

1126

8171

(3044889) 12 lead EKG panel

2775

21116

2.31

100.16

4.7

4.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

168

279

6.26

97.09

3.8

4.5

325.70

354.94

umol/l

1.44

144

237

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2128

14722

2.07

96.82

5.2

6.0

1.21

mmol/l

0.87

1993

13346

(3002582) Erythrocytes [#/volume] in Urine

1582

9846

2.07

96.07

3.7

3.4

62.47

88.27

e6/l

0.81

1087

7649

(3018677) aPTT in Platelet poor plasma by Coagulation assay

983

5154

2.24

92.53

2.1

2.0

29.80

30.06

0.63

954

4977

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1833

12175

2.02

91.48

2.3

2.2

77.56

79.89

nmol/l

2.89

1630

10653

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2260

16250

2.03

89.08

6.0

6.8

1.22

1.21

mmol/l

1.74

2073

13712

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1546

9738

2.02

88.90

2.3

2.1

244.20

223.85

u/l

0.31

1445

9060

(3031040) Bacteria [#/volume] in Urine by Automated count

2664

20459

2.12

85.94

6.2

5.0

613.58

2024.84

e6/l

1.34

309

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

511

2069

2.71

84.27

1.9

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3174

26319

2.59

82.92

5.9

4.9

1.85

2.06

mu/l

3.88

2950

23554

(3037467) Urinalysis macro (dipstick) panel - Urine

2690

20898

2.09

81.72

5.6

4.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

701

3376

2.33

79.43

2.4

2.7

7.86

9.68

umol/l

1.69

561

2944

(3013826) Glucose [Moles/volume] in Serum or Plasma

2445

18554

1.96

76.66

4.7

6.67

6.84

mmol/l

3.30

2248

17425

(3016018) Differential panel - Cerebral spinal fluid

140

247

5.85

75.97

1.3

—

(40758558) Short blood count panel - Blood

1249

7615

1.97

75.93

6.4

6.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2884

23564

2.07

68.28

7.3

7.8

80.14

80.90

u/l

0.27

2700

22090

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3322

28768

2.74

68.21

21.6

16.6

27.85

25.86

mg/l

2.67

2729

23425

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2692

21661

1.93

63.96

4.1

4.0

14.59

15.06

pmol/l

18.23

2425

19283

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

389

1581

2.63

62.83

3.2

3.7

24.04

24.22

mmol/l

0.47

361

1541

(3022096) Basophils/100 leukocytes in Blood

1871

13605

1.77

60.72

5.8

5.9

0.65

0.66

0.04

1717

12582

(3018010) Neutrophils/100 leukocytes in Blood

1925

14121

1.77

60.52

5.9

5.8

58.63

58.17

0.91

1776

13101

(3006504) Eosinophils/100 leukocytes in Blood

1905

14000

1.76

58.88

5.8

5.9

2.83

2.82

0.02

1748

12960

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

926

5491

1.92

58.37

2.1

1.9

—

(3019069) Monocytes/100 leukocytes in Blood

1911

14078

1.75

58.36

6.0

6.2

8.78

8.89

0.74

1757

13037

(3024891) Influenza virus A+B Ag [Presence] in Specimen

218

667

3.41

58.33

1.3

1.2

—

(3026008) Bacteria identified in Urine by Culture

1527

10620

1.75

56.61

4.0

3.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

1929

14334

1.73

56.33

5.9

6.1

26.14

26.52

0.76

1779

13309

(3019550) Sodium [Moles/volume] in Serum or Plasma

3389

30197

2.73

55.30

25.8

19.9

139.56

139.52

mmol/l

0.36

3310

29402

(3023103) Potassium [Moles/volume] in Serum or Plasma

3390

30255

2.71

54.29

26.1

20.1

3.95

3.99

mmol/l

18.47

3305

29407

(3014111) Lactate [Moles/volume] in Serum or Plasma

571

2961

2.10

52.03

5.1

6.2

1.31

1.37

mmol/l

0.80

546

2868

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1902

14303

1.69

51.18

3.0

2.4

—

(40761511) CBC panel - Blood by Automated count

3313

29415

2.38

50.85

17.7

16.0

—

(3001604) Monocytes [#/volume] in Blood

1958

14864

1.69

50.60

5.7

5.6

0.61

e9/l

0.20

1517

12644

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

402

1832

2.34

50.31

6.0

8.2

24.54

24.37

mmol/l

0.44

368

1762

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1255

8470

1.73

50.21

2.4

2.3

2.53

3.12

mg/l

16.26

1029

7223

(3006315) Basophils [#/volume] in Blood

1960

14911

1.68

50.00

5.7

5.6

0.04

e9/l

0.10

1518

12691

(3019198) Lymphocytes [#/volume] in Blood

1983

15212

1.67

48.29

5.7

1.95

1.92

e9/l

0.16

1567

13258

(3000991) Gas panel - Venous blood

541

2826

2.07

48.07

5.5

7.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

103

7.11

47.87

2.1

2.2

54.64

48.56

umol/l

0.68

(3011397) Hemoglobin [Presence] in Urine by Test strip

1079

7088

1.74

46.88

3.3

3.9

—

(3013115) Eosinophils [#/volume] in Blood

1992

15388

1.65

46.43

6.2

5.8

0.19

0.20

e9/l

0.08

1566

13287

(3023368) Bacteria identified in Blood by Culture

1336

9331

1.68

46.15

5.2

4.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

467

2371

2.11

44.56

1.8

1.7

1.60

1.56

0.47

396

2020

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1635

12140

1.63

43.69

3.1

2.9

104.89

149.82

ug/l

20.71

1515

11030

(3013650) Neutrophils [#/volume] in Blood by Automated count

2184

17462

1.62

42.65

8.3

8.8

4.31

4.25

e9/l

0.52

1745

15125

(3026782) Osmolality of Urine

1016

6712

1.71

42.48

2.9

3.0

570.68

532.86

mosm/kgh2o

6.15

742

5758

(3009542) Hematocrit [Volume Fraction] of Blood

3423

31298

2.53

41.05

31.5

24.7

39.18

39.42

1.41

3089

28916

(3035941) MCH [Entitic mass]

3424

31316

2.53

40.95

31.1

24.5

30.36

30.39

0.46

3359

30735

(3024731) MCV [Entitic volume]

3424

31317

2.53

40.93

31.1

24.6

91.60

91.57

0.11

3359

30738

(3026361) Erythrocytes [#/volume] in Blood

3424

31318

2.53

40.91

31.2

24.7

4.38

4.41

e12/l

2.51

3308

30250

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3356

30434

2.29

40.91

12.3

11.3

25.08

25.06

u/l

0.01

3222

29119

(3007461) Platelets [#/volume] in Blood

3423

31310

2.52

40.80

31.1

24.7

238.99

243.98

e9/l

4.53

3320

30367

(3000963) Hemoglobin [Mass/volume] in Blood

3424

31326

2.52

40.74

31.4

24.8

131.48

133.07

g/l

7.99

3360

30761

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

585

3316

1.91

40.65

2.3

3.1

233.32

252.73

ng/l

0.39

536

3025

(3010813) Leukocytes [#/volume] in Blood

3423

31318

2.51

40.63

31.2

24.7

6.89

6.87

e9/l

0.22

3308

30241

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1278

9059

1.63

40.29

3.1

38.54

37.20

u/l

0.13

1155

8543

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2156

17315

1.60

40.18

3.4

3.1

48.55

55.22

u/l

2.07

1941

15757

(3029937) Albumin [Presence] in Urine by Test strip

468

8025

0.52

37.38

5.0

4.4

0.00

estimate

1.08

122

2692

(3036489) Thrombin time

244

1030

2.47

35.93

1.8

1.9

21.77

21.73

0.02

220

922

(3013707) Erythrocyte sedimentation rate by Westergren method

2594

22044

1.61

35.78

4.1

4.3

12.93

14.29

mm/h

4.44

2376

20160

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3060

27161

1.79

35.54

6.5

6.4

39.97

40.64

mmol/mol

3.51

2857

24666

(1761868) Lipid panel - Serum or Plasma

519

8501

0.55

35.13

3.1

3.2

—

(1002224) Polysomnography panel

199

772

2.67

34.89

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2033

16466

1.53

33.62

5.2

6.3

12.26

12.02

umol/l

0.35

1893

15640

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3144

28254

1.82

33.38

5.2

5.1

6.02

6.05

mmol/l

0.58

2851

25184

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3192

28831

1.86

33.14

5.7

5.4

2.53

2.62

mmol/l

6.69

2943

25995

(3052851) Hemolysis interference index of Serum or Plasma

232

1001

2.41

32.53

3.1

3.5

—

(3021589) Normoblasts [#/volume] in Blood

1676

13117

1.51

31.94

7.9

10.2

0.00

e9/l

0.08

1166

10661

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

228

985

2.40

31.87

2.0

2.5

0.00

g/l

-0.00

192

915

(3002032) Base excess in Venous blood by calculation

541

3227

1.79

31.33

3.1

3.6

1.59

2.00

mmol/l

1.56

453

2696

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

228

997

2.37

31.01

2.0

2.4

0.00

g/l

0.50

192

916

(3021447) Carbon dioxide [Partial pressure] in Venous blood

538

3245

1.77

29.90

3.1

3.6

5.84

5.83

kpa

0.09

503

3141

(3027801) Oxygen [Partial pressure] in Arterial blood

633

3998

1.71

29.85

5.9

6.7

11.98

12.03

kpa

0.09

581

3787

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

633

3998

1.71

29.85

5.9

6.7

5.10

5.09

kpa

0.10

583

3784

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

235

1060

2.30

29.75

2.0

2.4

0.03

0.05

g/l

0.43

197

976

(3003396) Base excess in Arterial blood by calculation

630

3994

1.70

29.25

5.9

6.7

0.80

1.14

mmol/l

1.06

510

3138

(3024354) Oxygen [Partial pressure] in Venous blood

459

2657

1.83

29.23

2.6

3.0

4.45

4.50

kpa

0.22

422

2565

(3013512) EKG study

671

9860

0.61

28.80

4.2

4.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

194

819

2.45

28.52

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

195

829

2.43

28.23

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

980

6981

1.55

28.09

2.5

2.6

4.98

5.31

e6/l

0.40

808

6249

(42529406) Shigella sp [Presence] in Stool by Culture

195

836

2.41

27.71

1.2

—

(3024928) Oxygen saturation in Venous blood

170

684

2.56

27.67

1.9

2.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

151

4.50

27.55

1.1

1.0

—

(36660697) Celiac disease serology panel - Serum

360

1968

1.92

27.34

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

736

4961

1.61

26.59

1.4

1.5

2.51

2.58

g/l

0.28

320

2890

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

809

5578

1.58

26.54

1.3

1.2

3.75

1.55

u/ml

1.22

105

1404

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

911

6460

1.55

26.37

1.9

1.7

1.38

1.40

mg/l

0.05

676

5018

(40760892) CBC W Ordered Manual Differential panel - Blood

1730

14029

1.44

25.33

5.4

6.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

775

5358

1.57

24.93

2.4

3.0

0.81

mmol/l

1.20

665

4971

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

232

1119

2.15

24.89

2.0

2.3

37.16

37.36

g/l

0.19

194

981

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

200

4010

0.47

24.27

5.0

4.8

32.62

33.45

0.53

146

2616

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

319

1748

1.90

23.97

2.3

2.4

29.09

23.21

au/ml

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

819

11147

0.66

23.64

4.6

4.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

179

3.91

23.62

1.7

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

848

6065

1.52

23.14

3.3

0.80

0.81

ug/l

0.06

598

4297

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

292

1576

1.93

22.95

1.2

1.3

42.76

60.75

au/ml

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

231

1148

2.08

22.91

2.3

2.2

819.85

552.98

ug/l

0.39

213

1090

(3023183) Ammonium ion [Moles/volume] in Plasma

147

606

2.49

22.76

2.1

2.6

29.17

35.77

umol/l

2.07

123

533

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

240

1214

2.05

22.70

2.0

2.5

0.60

1.11

g/l

1.85

199

1045

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

210

1019

2.13

22.18

1.1

—

0.90

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1908

15975

1.41

22.14

22.7

18.9

1.32

1.36

inr

0.63

305

4606

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2991

27249

1.54

21.66

21.2

16.0

75.18

73.72

ml/min/173m2

3.39

2405

22672

(3051611) Lipemic interference index of Serum or Plasma

102

360

2.89

21.46

3.0

3.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

221

4088

0.51

20.88

8.5

7.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

227

1161

2.02

20.82

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

708

4972

1.53

20.77

2.2

2.5

2.23

2.28

g/l

1.87

653

4586

(3000492) Spirometry study

407

2505

1.70

20.64

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

1327

1.95

20.62

2.1

2.4

3.02

3.01

g/l

0.03

211

1190

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

252

1342

1.94

20.58

2.1

2.4

10.31

10.29

g/l

0.02

212

1195

(40761536) Microorganisms panel - Urine sediment

110

2609

0.40

20.44

5.1

4.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

740

5311

1.49

19.41

2.2

2.5

11.78

12.31

umol/l

1.21

688

4935

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

159

741

2.20

18.62

2.4

2.3

189.66

202.60

1.11

146

703

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

1429

1.86

18.39

2.1

2.4

7.23

7.49

g/l

1.67

218

1293

(3000494) Fungus identified in Specimen by Culture

514

3452

1.57

18.25

1.6

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

662

4697

1.50

18.25

2.4

2.6

20.90

21.70

0.73

555

4018

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1426

1.86

18.21

2.1

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1426

1.86

18.21

2.1

2.4

3.68

3.65

g/l

0.14

217

1291

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1086

8467

1.40

18.06

4.9

4.7

22.90

22.02

0.90

430

4464

(3027945) Reticulocytes/100 erythrocytes in Blood

594

4131

1.52

17.99

2.0

2.4

1.76

1.81

0.61

495

3637

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1015

7861

1.40

17.42

1.6

1.32

1.33

mmol/l

0.13

948

6477

(3015736) pH of Urine

1428

11701

1.36

17.32

3.5

3.7

5.84

5.81

0.09

537

(1001926) Buprenorphine [Presence] in Urine by Screen method

294

2.83

16.83

6.2

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

163

806

2.07

16.41

2.0

2.1

93.70

89.20

1.59

152

778

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

186

967

1.97

16.30

1.8

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

305

1849

1.71

16.25

7.6

9.0

—

(3028707) Methadone [Presence] in Urine by Screen method

167

3.39

15.72

8.3

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

155

765

2.07

15.70

1.7

1.6

—

(3019225) pH of Specimen

192

3408

0.54

15.58

3.8

4.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

378

2448

1.61

15.56

1.7

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

138

2718

0.49

15.55

4.2

4.0

0.83

0.96

0.24

995

(3021440) Promyelocytes/100 leukocytes in Blood

129

2593

0.48

15.42

3.9

4.0

0.15

0.11

0.26

870

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

401

2646

1.58

15.25

3.1

3.7

90.13

96.72

ng/l

0.88

334

2244

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

250

2.88

15.10

1.2

1.1

—

2.22

—

(3002179) Metamyelocytes/100 leukocytes in Blood

121

2465

0.47

15.02

3.6

3.8

0.43

0.72

2.14

842

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

4.39

14.96

2.2

2.7

27.36

28.44

umol/l

0.19

(3044640) Blood type and Crossmatch panel - Blood

1233

10054

1.34

14.81

2.7

2.6

—

(3048689) Calprotectin [Mass/mass] in Stool

443

3011

1.54

14.75

2.0

2.1

106.66

153.59

ug/g

2.87

345

2333

(3011288) Drugs identified in Urine by Screen method

250

2.84

14.52

7.5

2.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

283

1733

1.69

14.51

1.7

1.8

1.53

g/l

0.02

233

1502

(3025159) Blasts/100 leukocytes in Blood

120

2420

0.48

14.46

4.1

4.0

1.22

0.26

0.36

706

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

978

7721

1.36

14.44

2.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

566

7644

0.69

14.01

4.1

3.8

—

(3051651) Icteric interference index of Serum or Plasma

191

3.07

13.90

3.1

3.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

155

2816

0.53

13.53

3.8

3.9

1.23

mmol/l

0.03

135

2471

(3006653) Thiamine [Moles/volume] in Blood

125

3.55

13.34

1.2

128.63

142.59

nmol/l

0.77

125

(3042936) Bacteria identified in Isolate by Culture

619

4610

1.41

12.81

2.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

155

824

1.92

12.78

2.3

3.57

3.64

g/l

0.24

147

781

(3016879) Cocaine [Presence] in Urine

352

2.42

12.69

6.0

1.8

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

302

1949

1.60

12.57

5.2

6.5

25.07

24.95

mmol/l

0.22

302

1935

(3019832) Treponema pallidum Ab [Presence] in Serum

194

1116

1.78

12.45

1.5

—

(3036180) Methadone [Presence] in Urine

5.13

12.20

3.8

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

329

2.43

12.12

1.2

5.89

5.61

u/ml

0.04

150

(3000764) Benzodiazepines [Presence] in Urine

382

2.28

11.43

5.9

1.7

—

(3028300) Cannabinoids [Presence] in Urine

384

2.27

11.29

6.0

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2967

27828

1.36

11.18

4.3

4.7

1.43

1.46

mmol/l

2.94

2670

25018

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

218

2.69

11.01

1.3

1.2

86.00

138.50

titre

—

(3027008) Opiates [Presence] in Urine

382

2.25

11.00

6.0

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

126

660

1.94

10.90

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

208

2.72

10.88

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

128

3.23

10.80

1.9

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

211

1299

1.66

10.63

2.6

2.9

0.34

u/ml

0.00

110

771

(3027944) Amphetamines [Presence] in Urine

377

2.23

10.49

6.3

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

453

3319

1.42

10.16

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

492

3660

1.40

10.10

2.0

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2980

28078

1.34

10.04

4.4

4.7

4.41

4.52

mmol/l

6.42

2711

25436

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

241

2.51

10.00

1.6

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

145

2.99

9.98

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

375

2.19

9.80

3.7

3.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

344

2.24

9.72

1.2

9.04

3.08

u/ml

0.73

104

(46235355) HIV 1 and 2 tests - Meaningful Use set

435

3189

1.41

9.71

1.7

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

444

3269

1.41

9.67

7.0

7.4

119.95

119.76

g/l

0.07

429

3174

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1240

10564

1.26

9.64

5.3

5.5

3.98

4.31

ug/l

0.11

1082

9399

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

3.93

9.57

1.7

2.1

167.63

200.97

0.54

(3003458) Phosphate [Moles/volume] in Serum or Plasma

573

4407

1.36

9.55

4.3

5.6

1.01

1.04

mmol/l

2.25

493

4075

(3000570) Elastase.pancreatic [Mass/mass] in Stool

158

930

1.73

9.43

1.4

266.33

270.47

ug/g

0.08

557

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.35

9.29

1.3

2.7

119.11

102.13

umol/l

0.16

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.47

9.18

1.3

—

(40768797) Stomach Pathology biopsy report

553

4288

1.34

8.69

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

169

2.68

8.63

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2856

26902

1.28

8.60

3.8

4.2

1.26

1.28

mmol/l

0.97

2506

23937

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

605

0.24

8.06

4.2

3.5

59.53

58.68

0.09

605

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

273

1900

1.47

8.05

1.6

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

159

2.66

7.96

1.2

1.1

32.95

46.72

mg/l

2.29

133

(3016502) Oxygen saturation in Arterial blood

467

3578

1.35

7.91

6.8

7.0

95.40

95.48

0.09

445

3434

(3036481) Cortisol [Moles/volume] in Serum or Plasma

356

2612

1.40

7.88

2.0

2.2

395.52

376.56

nmol/l

0.85

317

2367

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

235

1596

1.50

7.83

2.5

3.2

4.30

4.38

pmol/l

0.61

196

1384

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

171

2.53

7.41

1.2

30.82

20.52

u/l

0.61

143

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

148

2.65

7.38

1.2

1.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

401

3043

1.36

7.22

2.0

2.1

0.21

0.20

g/l

2.49

342

2828

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

132

2104

0.61

7.07

3.5

3.6

1.58

2.03

mmol/l

0.82

1549

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

238

2.24

7.01

1.1

1.2

95.43

94.01

0.12

224

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

141

2208

0.62

7.01

3.5

3.7

5.08

5.16

kpa

0.55

130

2086

(3022313) Gas panel - Capillary blood

1579

0.56

7.00

3.9

3.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

578

4652

1.29

6.85

1.3

44.48

39.70

iu/ml

0.16

140

1431

(3009343) pH of Capillary blood

140

2184

0.63

6.84

3.4

3.7

7.42

7.41

0.18

278

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

172

2.46

6.83

1.3

1.4

13.88

14.50

umol/l

0.20

162

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

191

1282

1.52

6.76

2.0

1.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

179

2.42

6.76

1.2

109.61

94.05

u/l

0.32

153

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

4.27

6.74

1.2

1.4

116.33

130.48

ug/l

—

(40768804) Tissue Pathology biopsy report

1384

12276

1.21

6.68

2.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

108

632

1.73

6.68

1.2

1.1

5.61

11.54

u/ml

0.60

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

428

1.89

6.64

1.2

—

(3039000) Anion gap in Blood

124

755

1.66

6.63

6.9

7.2

11.23

11.04

mmol/l

0.25

111

666

(3018572) Chloride [Moles/volume] in Blood

124

755

1.66

6.63

6.9

7.2

105.57

104.94

mmol/l

0.66

111

666

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1402

0.55

6.62

2.0

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

971

8350

1.22

6.39

2.4

2.9

10979.05

5879.84

umol/l

1.60

784

7117

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

2.52

6.34

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

229

2.20

6.34

2.1

2.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

179

1207

1.51

6.22

1.1

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

489

1.80

6.20

2.1

1.6

289.50

287.81

mu/l

0.02

448

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

138

2.55

6.19

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.13

6.16

1.1

1.2

170.50

120.54

nmol/l

0.45

(3014891) Appearance of Pleural fluid

3.52

6.15

1.3

1.2

—

(3044941) Cell count panel - Synovial fluid

520

1.77

6.14

1.5

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

391

3035

1.32

6.05

2.1

2.6

65.77

66.23

g/l

0.60

337

2746

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

187

1284

1.48

5.97

3.1

292.00

4178.40

u/ml

1.08

145

1082

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

323

1.97

5.97

1.0

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

753

0.42

5.96

1.8

3.3

21.48

927.34

u/ml

1.70

690

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

310

1.98

5.92

1.0

1.1

120.30

114.54

0.66

272

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

112

2.69

5.91

1.9

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

124

2.59

5.87

1.3

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

327

2485

1.35

5.84

1.5

—

(40761535) Cells panel - Urine sediment

196

2759

0.69

5.79

3.6

—

(1616796) Gas panel - Central venous blood

812

0.45

5.77

3.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

265

1956

1.38

5.70

1.4

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

121

2.58

5.62

1.8

2.4

97.03

97.60

0.03

114

(44816559) Phosphatidylethanol [Mass/volume] in Blood

409

1.83

5.61

1.3

—

(3047181) Lactate [Moles/volume] in Blood

159

1072

1.51

5.57

6.4

6.2

1.40

1.29

mmol/l

0.58

142

942

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.63

5.48

1.6

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

1629

14849

1.18

5.39

3.8

4.1

0.00

estimate

1.08

118

2750

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1295

0.58

5.38

1.8

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

149

2.36

5.31

2.6

1.7

14.60

16.69

nmol/l

1.06

134

(3000012) Reticulocyte production index

544

0.36

5.25

1.4

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

1609

14674

1.17

5.24

3.8

4.0

0.00

estimate

1.15

141

3042

(3021601) Nitrite [Presence] in Urine by Test strip

1607

14671

1.17

5.13

5.9

5.4

0.00

estimate

-0.00

126

2806

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.20

5.07

2.3

1.9

14.88

17.30

umol/l

0.40

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1321

0.60

5.03

4.1

4.0

24.74

24.86

mmol/l

0.10

1210

(3025130) Human papilloma virus identified in Specimen

215

2.06

4.82

1.5

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

150

1034

1.47

4.76

1.2

1.3

—

(3020891) Body temperature

1403

0.63

4.64

4.7

4.5

—

(4146454) Self-monitoring of blood glucose

391

0.30

4.58

1.7

2.7

—

(40767503) Oxygen content in Capillary blood by calculation

796

0.51

4.58

3.1

2.5

16.84

15.74

0.87

415

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

497

4116

1.24

4.57

3.4

4.1

252.97

248.30

u/l

0.20

452

3880

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

391

3155

1.27

4.51

2.2

2.5

5.15

7.04

ug/l

2.97

322

2747

(3013290) Carbon dioxide [Partial pressure] in Blood

791

0.51

4.50

3.9

4.7

5.00

5.04

kpa

0.15

778

(3012501) Base excess in Blood by calculation

790

0.51

4.48

3.9

4.7

2.50

2.87

mmol/l

0.42

549

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

163

1156

1.43

4.47

2.0

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

298

0.30

4.46

3.2

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

365

1.77

4.45

1.5

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

825

0.53

4.41

2.3

2.2

195.02

95.44

ug/min

0.42

489

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

349

2785

1.28

4.41

1.5

—

(3019150) Specific gravity of Urine by Refractometry

548

6476

0.82

4.41

4.3

4.5

1.01

1.02

kg/l

1.08

102

1036

(3005011) Chlamydia sp Ab [Titer] in Serum

4.07

4.40

2.0

1.7

—

(3042631) Mycobacterium sp identified in Specimen

512

0.41

4.36

5.7

2.8

—

(3028717) Thiamine [Mass/volume] in Blood

4.66

4.36

1.1

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

244

1858

1.34

4.36

2.3

2.1

13.43

11.92

nmol/l

1.74

220

1616

(3021879) Hepatitis B virus core Ab [Presence] in Serum

212

1584

1.36

4.29

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

500

1.63

4.24

1.4

1.3

29.59

30.33

iu/l

0.07

416

(3023511) Choriogonadotropin [Units/volume] in Urine

152

2.18

4.23

1.6

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

192

2.04

4.23

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

192

2.04

4.23

1.7

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

435

3583

1.24

4.21

1.3

552.57

552.89

titre

0.00

816

(4034850) Laboratory test

974

0.58

4.15

7.5

11.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

8.01

4.06

6.5

10.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

594

6913

0.83

4.05

1.6

1.7

20543093.83

25507895.12

pmol/l

0.09

516

5567

(3016650) Hepatitis A virus Ab [Presence] in Serum

392

1.70

4.02

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

734

0.53

3.99

4.1

3.7

36.13

28.47

mg/l

0.59

468

(3043409) Potassium [Moles/volume] in Arterial blood

1060

0.61

3.96

3.7

4.0

3.84

3.91

mmol/l

0.45

1052

(3007930) Methemoglobin/Hemoglobin.total in Blood

193

1443

1.36

3.92

5.6

5.2

0.95

0.88

2.04

179

1347

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

8.76

3.77

1.6

1.3

547.76

231.85

nmol/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

597

1.54

3.73

2.0

1.8

—

(40768443) Skin Pathology biopsy report

189

1421

1.35

3.72

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

583

0.49

3.67

3.3

3.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

200

0.25

3.67

1.2

2.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.64

3.65

1.3

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

482

1.59

3.62

2.0

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

102

1478

0.68

3.62

2.4

1.9

1.11

2.15

ug/l

1.38

1305

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

215

0.28

3.62

4.0

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

215

0.28

3.62

4.0

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

429

1.62

3.57

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

392

1.64

3.52

1.9

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

237

1861

1.29

3.45

2.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

595

0.52

3.43

1.9

1.6

—

(21494755) Public health laboratory ask at order entry panel

1260

0.67

3.41

1.3

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

160

2.01

3.39

1.3

1.5

6.28

7.52

u/l

0.43

137

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.58

3.38

1.1

104.61

100.47

0.14

(3021901) Oxygen saturation in Capillary blood

707

0.56

3.37

3.0

2.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

175

1.95

3.33

1.1

2.36

8.40

nmol/l

—

(3049717) Cytology report of Urine Cyto stain

187

1429

1.33

3.33

2.3

2.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

241

0.33

3.28

3.3

1.4

—

(3021788) Differential panel - Synovial fluid

592

1.50

3.26

1.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.34

3.22

1.1

120.20

82.23

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.18

3.19

1.6

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

318

1.68

3.18

1.2

62.51

60.79

u/l

0.05

287

(3010838) Calcium [Moles/time] in 24 hour Urine

539

1.51

3.17

1.8

5.34

4.60

mmol/24h

0.96

453

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1546

14408

1.13

3.13

2.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

188

1452

1.31

3.12

5.7

5.2

1.68

1.56

1.16

175

1355

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.54

3.12

1.1

88.33

80.37

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

111

2.17

3.12

1.5

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.44

3.10

2.0

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

468

0.49

3.07

2.2

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

773

0.60

3.04

1.7

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

676

1.45

3.04

1.7

1.6

—

(3003181) Sodium [Moles/volume] in Urine

660

1.45

3.02

1.3

58.82

60.24

mmol/l

0.13

524

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.29

2.99

1.0

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

109

780

1.41

2.96

1.8

1.5

0.23

0.24

g/l

0.12

738

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.47

2.95

1.1

1.3

82.00

80.00

—

(3004588) Protein electrophoresis panel - Serum or Plasma

308

2545

1.23

2.94

2.2

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

370

0.46

2.77

3.3

4.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

111

808

1.39

2.76

1.8

1.4

1.19

1.17

g/l

0.23

765

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

419

1.54

2.74

1.1

1.3

120.69

123.18

u/ml

0.08

(40759836) Histone Ab [Presence] in Serum by Immunoblot

188

1.82

2.74

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

188

1.82

2.74

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

188

1.82

2.74

1.0

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

800

0.63

2.74

1.6

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

286

1.65

2.72

1.2

1.0

1.96

2.21

u/ml

0.10

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

458

0.52

2.68

2.0

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.28

2.67

1.1

—

(3010421) pH of Blood

915

0.66

2.67

3.5

4.5

7.42

0.25

838

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.79

2.62

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.79

2.62

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.79

2.62

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

134

1.95

2.60

1.5

1.0

0.97

1.19

u/l

1.91

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

764

0.64

2.58

1.2

—

(3034426) Prothrombin time (PT)

2.30

2.57

1.1

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.15

2.55

1.2

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

201

1.75

2.52

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

109

808

1.36

2.46

1.5

1.6

10983.89

14323.08

e6/l

0.71

584

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

457

0.54

2.46

2.0

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

116

1.99

2.45

1.1

—

(4035726) Immunohistochemistry procedure

247

2976

0.82

2.44

1.3

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

457

1.47

2.41

1.7

1.5

64601.83

75896.03

e6/l

0.09

280

(3034092) Cytoplasmic Ig cells/100 cells in Blood

3.34

2.39

6.8

8.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

514

0.58

2.35

1.9

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

436

1.48

2.33

6.2

6.4

11.93

12.22

mg/l

0.20

405

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

780

0.66

2.32

3.1

2.7

1.41

1.70

mg/l

2.49

696

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

141

1.85

2.27

1.1

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

278

1.59

2.25

1.3

1.6

17.09

23.38

u/ml

0.80

(3005719) IgG [Mass/volume] in Serum or Plasma

256

2139

1.21

2.25

1.9

2.7

10.41

10.67

g/l

0.34

231

1940

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

2.24

0.0

2.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

591

1.40

2.22

1.2

1.1

—

(40768793) Breast Pathology biopsy report

712

0.66

2.21

1.1

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

594

1.39

2.17

1.6

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

502

1.42

2.15

1.7

1.5

954.49

1639.85

e6/l

1.99

372

(3029075) Extractable nuclear Ab panel - Serum

2.17

2.14

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

372

0.54

2.12

2.6

3.8

62.73

57.08

0.50

310

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

279

0.46

2.11

1.2

1.1

—

3.13

—

(4200892) Spirometry reversibility

262

2209

1.20

2.11

1.4

—

(3016038) Potassium [Moles/volume] in Urine

228

1.63

2.11

1.1

31.37

34.84

mmol/l

0.48

189

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

460

0.58

2.11

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

305

0.49

2.10

1.2

1.6

—

(3045424) Erythrocytes [Presence] in Urine

520

0.61

2.08

1.4

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.98

2.05

1.4

1.2

—

(3017569) Oxygen content in Arterial blood

193

0.41

2.04

1.8

2.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

194

0.41

2.03

8.9

3.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

209

1.63

1.97

1.9

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

424

0.59

1.94

1.2

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

522

1.39

1.93

1.3

1.2

32.39

37.91

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

472

1.41

1.91

1.1

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

422

0.59

1.91

1.2

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

113

1.86

1.91

1.6

2.3

7721.57

965.22

e6/l

0.43

(3022493) Free Hemoglobin [Mass/volume] in Plasma

122

1.81

1.84

5.7

5.5

78.12

61.42

mg/l

0.57

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.58

1.80

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

116

1.82

1.78

1.2

1.3

1.52

1.56

g/l

0.23

116

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

168

0.42

1.78

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

192

1.62

1.77

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

424

0.61

1.76

1.2

1.4

—

(3033799) Differential panel - Peritoneal fluid

102

1.87

1.76

1.6

2.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

741

1.30

1.74

1.4

1.7

3.50

3.99

mg/l

0.20

568

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.74

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

483

0.64

1.73

2.2

1.8

88.59

89.33

0.33

477

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

445

0.63

1.71

1.9

21.20

25.17

ug/l

0.28

437

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

1.70

0.0

2.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.00

1.69

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

217

2547

0.84

1.69

2.5

2.7

67.16

60.00

ml/min/173m2

1.98

1126

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

281

0.53

1.69

1.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

281

0.53

1.69

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

281

0.53

1.69

1.3

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

305

0.56

1.66

1.2

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.80

1.65

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.80

1.65

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

2.80

1.65

1.4

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.80

1.65

1.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

953

0.75

1.64

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.98

1.64

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

341

0.58

1.63

1.9

3.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

427

0.63

1.62

1.2

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

390

0.61

1.62

2.0

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

158

1.65

1.62

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

120

1.75

1.62

2.6

2.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.57

1.61

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.84

1.61

1.7

2.2

20561.91

26603.83

e6/l

0.12

(3026480) Teichoate Ab [Titer] in Serum

2.50

1.59

1.3

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

388

0.62

1.59

1.7

2.1

1.25

1.39

g/24h

—

202

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

423

0.64

1.57

1.2

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

449

1.36

1.55

1.2

1.3

197.43

225.01

miu/ml

0.25

171

(3042517) Benzodiazepines panel - Urine

3.34

1.52

20.6

1.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.00

1.52

0.0

2.3

—

45.81

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

112

1384

0.80

1.51

1.2

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

514

0.68

1.51

1.1

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.16

1.50

1.2

1.3

173.02

652.56

u/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.16

1.50

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

643

1.30

1.50

1.5

1.8

4.32

4.59

iu/l

0.08

196

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

184

0.49

1.50

1.2

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

184

0.49

1.50

1.2

1.3

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.00

1.49

0.0

1.3

—

7.09

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

147

1763

0.83

1.48

2.3

2.8

0.26

0.31

e6/l

0.18

141

1727

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

139

1.66

1.48

1.0

1.1

—

(4212803) Bone marrow aspirate examination

2.44

1.47

1.3

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

254

0.55

1.45

1.1

—

56.09

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

568

0.70

1.45

1.7

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

412

1.36

1.44

1.1

1.2

301.76

281.34

u/ml

0.23

247

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.12

1.44

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

312

2765

1.14

1.42

1.7

1.5

—

(3044007) Cell count panel - Peritoneal fluid

1.82

1.41

2.0

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

136

0.44

1.40

1.5

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

599

1.29

1.37

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

324

0.62

1.37

1.2

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

444

0.67

1.37

2.3

31.09

24.75

mg/l

0.24

101

(3037121) Protein [Mass/volume] in Urine

1158

0.80

1.36

2.3

3.0

0.28

0.30

g/l

0.15

467

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.94

1.36

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

115

941

1.23

1.35

3.4

3.0

0.67

0.83

nmol/l

4.47

712

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

191

1.52

1.34

1.7

1.6

3.79

6.43

u/l

0.77

157

(40758292) HTLV I+II Ab panel - Serum

0.00

1.34

0.0

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

430

0.67

1.34

1.2

1.4

—

(3045414) Leukocytes [Presence] in Urine

113

1373

0.82

1.33

2.1

1.9

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

1.32

0.0

1.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

1.32

0.0

1.0

—

13.81

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

123

1479

0.83

1.30

1.6

1.8

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.50

1.30

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

765

1.25

1.30

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

232

0.56

1.30

1.1

—

3.67

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.85

1.29

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.85

1.29

1.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

133

0.45

1.27

1.3

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

133

0.45

1.27

1.3

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.94

1.27

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.00

1.27

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

304

0.62

1.26

1.4

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

563

1.28

1.26

1.6

31.00

31.20

g/l

0.05

504

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.86

1.23

1.3

1.7

68.54

177.66

nmol/24h

0.63

(3005322) IgE [Units/volume] in Serum or Plasma

172

1477

1.17

1.23

1.3

1.2

160.59

210.17

u/ml

0.72

157

1342

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.91

1.22

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

330

1.37

1.22

1.3

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.97

1.22

1.2

1.3

—

(3012441) Differential panel - Pleural fluid

435

1.32

1.20

1.8

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.11

1.18

1.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

248

1.42

1.16

1.2

1.4

564.00

210.00

titre

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

1.16

0.0

1.8

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

1.16

0.0

1.6

—

0.65

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

2.3

—

0.59

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

309

0.65

1.15

1.5

2.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.50

1.15

1.0

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1033

9822

1.07

1.13

2.5

59.57

60.15

u/l

0.09

931

9016

(3039443) Prostate specific Ag panel - Serum or Plasma

413

0.70

1.12

1.8

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

2.00

1.12

1.5

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

476

4395

1.10

1.08

1.3

1.2

10.77

13.15

u/ml

0.28

113

1589

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

166

0.54

1.07

1.2

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

166

0.54

1.07

1.2

1.5

—

(3010503) CD19 cells [#/volume] in Blood

166

0.54

1.07

2.2

1.9

0.19

0.14

e9/l

—

159

(3040151) Glucose [Moles/volume] in Capillary blood

420

0.71

1.07

4.5

7.0

6.79

7.35

mmol/l

0.33

353

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

444

1.29

1.06

1.1

—

(40768806) Pleura Pathology biopsy report

436

1.29

1.05

1.8

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

253

0.63

1.04

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

360

0.69

1.04

1.1

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.27

1.03

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

229

1.40

1.03

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

203

0.59

1.03

8.4

3.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.84

1.02

1.1

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

311

0.67

1.02

2.8

2.0

0.83

2.11

u/field

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

333

1.33

1.01

2.0

1.9

17750.63

1832.31

u/l

0.76

126

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

318

1.32

0.97

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.97

0.0

1.2

—

12.62

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

165

1.46

0.96

2.0

1.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

193

1710

1.14

0.95

1.6

1.8

1.25

1.44

g/l

0.54

175

1536

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

507

1.25

0.93

1.3

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.72

0.92

1.2

1.3

—

11.64

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

295

1.33

0.92

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

279

0.68

0.90

1.8

3.1

9.21

30.89

mg/l

2.09

215

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

465

1.25

0.89

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

141

1232

1.15

0.87

2.4

3.2

43.27

107.45

mg/l

0.80

121

1019

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

141

1234

1.15

0.86

2.9

2.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.82

0.85

1.0

1.1

—

(3024263) Appearance of Synovial fluid

187

1.39

0.85

1.2

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

398

1.26

0.83

1.5

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

112

0.53

0.83

1.2

1.3

—

(3016228) CD19 cells/100 cells in Blood

113

0.53

0.83

2.7

1.9

7.17

7.37

—

108

(3010144) Erythrocytes [#/volume] in Synovial fluid

319

0.72

0.82

1.2

1.3

477943.60

103365.42

e6/l

0.75

217

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

103

884

1.17

0.82

1.3

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

189

0.63

0.81

7.6

17.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

147

1.43

0.80

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

147

1.43

0.80

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

785

1.18

0.79

1.5

1.8

12.63

12.40

mg/l

0.09

718

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

4.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.67

0.78

5.9

7.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

199

0.65

0.78

2.0

1.6

94.23

87.42

umol/l

0.30

199

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

182

1.38

0.77

1.5

1.6

0.23

0.25

nmol/l

0.14

146

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

686

1.18

0.76

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.76

0.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.76

0.0

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.76

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.76

0.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

139

1229

1.14

0.75

2.4

3.2

48.17

65.13

mg/l

0.38

119

1017

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

244

0.70

0.75

1.2

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.64

0.75

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

613

0.81

0.74

1.3

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

379

1.24

0.73

1.1

1.48

1.55

g/l

0.54

337

(3047189) Immunofixation for 24 hour Urine

176

1.37

0.72

1.3

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

108

0.55

0.72

2.5

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

0.54

0.72

3.2

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

0.54

0.72

3.2

2.1

—

(3017732) Neutrophils [#/volume] in Blood

177

1960

0.90

0.71

3.4

3.3

4.82

5.81

e9/l

0.45

153

1492

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

489

0.80

0.71

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

241

0.70

0.71

1.2

1.3

—

(3008295) Osmolality of Serum or Plasma

336

1.25

0.70

1.1

1.3

285.48

276.02

mosm/kgh2o

0.86

251

(40760888) Immunoglobulin light chains.free panel - Serum

932

0.86

0.69

2.4

3.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

996

0.86

0.69

6.9

4.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

144

0.62

0.69

2.1

1.7

—

(3002256) Pathology report gross observation

439

4130

1.07

0.69

1.4

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

154

1381

1.12

0.69

1.5

9.47

23.06

u/ml

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

737

0.84

0.68

1.2

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.85

0.68

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.85

0.68

1.6

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.85

0.68

1.6

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.53

0.68

31.0

8.4

—

(3024869) Neuronal Ab [Presence] in Serum

1.53

0.68

1.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

261

0.73

0.67

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.54

0.67

3.0

1.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

560

1.18

0.64

2.3

4.8

61.60

3712.85

iu/ml

—

(3009508) Creatinine [Moles/volume] in Urine

1062

10275

1.05

0.63

3.5

3.1

7.09

7.04

mmol/l

0.16

894

8484

(3002079) Sodium [Moles/time] in 24 hour Urine

112

1.43

0.63

1.1

1.3

127.51

158.77

mmol/24h

0.82

112

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

138

1238

1.12

0.63

1.6

1.8

39.72

38.76

u/l

0.22

110

1051

(40768800) Prostate Pathology biopsy report

708

0.84

0.62

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.52

0.62

1.4

2.13

1.91

umol/l

0.59

(40765096) Chromosome analysis panel by Banding

101

0.59

0.62

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.63

0.62

10.6

13.5

7.35

5.51

mmol/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

176

0.68

0.61

3.8

1.6

0.60

3.42

u/field

—

116

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.60

0.0

1.0

—

27.92

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

290

1.24

0.59

1.4

1.3

16.06

11.94

u/l

0.54

267

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

210

1.29

0.58

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.58

0.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

754

1.14

0.57

1.2

13.33

40.52

u/ml

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

507

0.83

0.57

1.2

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

507

0.83

0.57

1.2

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.48

0.57

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

754

0.86

0.57

1.9

1.7

—

(3022621) pH of Urine by Test strip

193

2096

0.92

0.56

3.5

3.2

—

(3009871) Measles virus Ab [Titer] in Serum

1.46

0.56

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

230

1.26

0.55

2.7

5.1

274.64

41.17

u/ml

—

(3020779) Urea [Moles/volume] in Serum or Plasma

333

3134

1.07

0.55

5.5

6.7

10.00

11.17

mmol/l

2.27

309

2965

(3011985) Renin [Units/volume] in Plasma

394

1.20

0.54

1.7

1.3

88.02

50.98

mu/l

0.32

346

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.46

0.54

1.0

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.46

0.54

1.7

1.5

—

2284600.00

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.50

0.54

1.2

1.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

159

0.69

0.54

1.7

1.6

—

(40768441) Liver Pathology biopsy report

205

1.27

0.52

1.6

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

168

1543

1.09

0.52

1.2

105.91

132.57

iu/ml

0.43

550

(3004451) EKG impression Narrative

192

0.73

0.52

1.4

1.2

—

(3019060) Gas panel - Arterial blood

253

2365

1.07

0.51

4.8

4.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

251

1.24

0.51

1.1

1.73

4.44

u/ml

1.43

111

(3032773) Endomysium IgG Ab [Titer] in Serum

197

1.27

0.51

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.47

0.50

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

1.47

0.50

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

398

1.18

0.50

1.7

1.5

0.79

0.83

g/l

0.10

301

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.46

0.50

2.0

1.5

48.00

43.54

umol/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

136

1489

0.91

0.49

3.2

3.8

68.70

82.81

u/ml

0.23

125

1424

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

289

1.21

0.48

1.3

1.1

0.22

1.70

u/ml

3.15

147

(3037692) Legionella sp identified in Specimen by Organism specific culture

109

0.64

0.48

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

110

0.64

0.48

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

475

1.16

0.47

1.6

1.4

6.74

10.61

u/l

2.94

375

(3015171) Extractable nuclear Ab [Units/volume] in Serum

114

1034

1.11

0.47

1.2

0.22

1.26

u/ml

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

154

0.71

0.47

2.5

2.2

—

(3017704) Immunofixation for Urine

201

1.25

0.45

1.6

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.37

0.44

3.1

3.0

9.36

6.67

mg/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

166

1.27

0.43

1.7

1.6

7.28

6.96

umol/l

0.04

103

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1128

11015

1.03

0.43

2.7

3.2

1713.54

1763.28

ng/l

0.13

955

9618

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.41

0.43

1.5

2.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.61

0.43

3.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

218

0.78

0.42

1.1

1.2

—

(3003129) Base excess in Capillary blood by calculation

0.66

0.42

1.0

2.1

0.45

0.95

mmol/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1035

10606

0.97

0.42

3.6

3.8

7.86

9.49

mg/mmol

0.61

618

6639

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

392

0.84

0.42

1.5

62.48

63.82

0.06

254

(3052592) Norovirus Ag [Presence] in Stool

1.38

0.41

1.1

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.41

0.0

2.7

—

(3023520) Reticulocytes [#/volume] in Blood

330

3142

1.06

0.41

2.0

2.5

70.28

70.06

e9/l

0.03

179

2385

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.36

0.41

1.3

1.6

88.50

136.37

ng/l

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.40

0.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.3

—

4.66

—

(3014271) Vancomycin [Susceptibility]

194

0.77

0.40

2.4

3.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.40

0.0

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.31

0.39

1.3

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.41

0.39

28.3

8.0

—

(40758358) Immune stain study

0.00

0.39

0.0

1.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

410

1.15

0.38

1.3

0.73

0.68

nmol/l

0.46

389

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.39

0.38

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

158

0.76

0.37

3.8

4.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

134

1.27

0.36

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

224

0.80

0.36

1.8

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

202

0.79

0.36

1.1

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.65

0.35

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.65

0.35

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.65

0.35

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.65

0.35

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

288

0.83

0.35

1.4

27.82

25.59

0.14

181

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.36

0.34

2.8

—

47.44

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

490

1.12

0.34

2.7

2.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.34

0.34

1.2

1.1

0.22

0.44

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

246

1.18

0.34

1.1

0.39

1.35

u/ml

1.02

(3006270) Folate [Moles/volume] in Blood

265

1.17

0.33

1.2

370.80

350.85

nmol/l

0.19

211

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

210

0.81

0.33

2.2

2.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.68

0.33

1.8

1.2

—

(3022145) Colonoscopy Study observation

321

3346

0.96

0.32

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.35

0.32

1.2

1.3

1.89

1.64

mmol/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

637

1.10

0.31

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

240

1.17

0.30

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.31

0.30

1.2

2.0

11.73

9.08

0.93

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

981

0.93

0.28

1.6

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1244

12638

0.98

0.28

4.1

37.92

88.62

ng/l

0.88

766

9645

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

167

1.20

0.28

3.7

6.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

162

0.80

0.28

1.1

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

162

0.80

0.28

1.0

0.03

0.43

u/ml

—

(3044927) Protein electrophoresis panel - Urine

397

0.88

0.28

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

103

1.26

0.28

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

412

1.12

0.28

1.3

0.14

0.34

nmol/l

—

(3008898) HLA-B27 [Presence]

661

1.09

0.28

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.29

0.28

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

575

0.90

0.28

1.1

1.5

0.73

0.79

nmol/l

0.27

464

(3041354) Potassium [Moles/volume] in Venous blood

498

1.11

0.28

2.7

2.4

4.00

4.09

mmol/l

0.96

493

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

322

0.87

0.27

1.8

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

702

1.08

0.26

1.2

3.52

3.05

u/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

253

1.15

0.26

1.1

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.28

0.26

1.2

2.0

24.91

28.60

0.91

(3020650) Glucose [Presence] in Urine

0.70

0.26

1.4

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

225

1.16

0.26

1.7

2.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

367

1.12

0.26

1.2

1.3

331.76

302.13

pmol/l

0.30

311

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

367

1.12

0.26

1.3

1.4

682.47

302.83

u/l

0.51

349

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.67

0.25

1.0

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

166

1742

0.95

0.24

4.0

3.4

25.81

25.12

mmol/l

2.01

159

1692

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.24

1.1

—

(3000330) Specific gravity of Urine by Test strip

171

1792

0.95

0.24

4.9

3.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

379

1.11

0.23

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

389

1.11

0.23

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

908

0.93

0.23

1.4

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.28

0.23

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.22

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

189

0.85

0.22

1.7

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.19

0.21

1.4

1.5

86.46

46.69

pmol/l

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.13

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

0.02

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.68

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.21

0.0

1.3

—

4.43

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.09

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

3.83

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

346

0.90

0.21

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

209

0.86

0.21

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.25

0.20

1.2

1.5

9.03

9.27

ug/l

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.20

0.0

1.1

—

0.05

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

112

0.80

0.20

1.0

—

(3035880) pH of Pleural fluid

222

1.13

0.19

1.2

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

827

0.94

0.18

2.1

2.3

126.97

126.72

g/l

0.02

600

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

164

0.85

0.18

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.19

0.18

1.0

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

195

0.87

0.17

1.7

2.0

70.29

72.16

0.24

181

(3042733) HLA Ab [Presence] in Serum

1.13

0.17

3.9

4.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.13

0.17

2.1

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

247

0.89

0.17

1.7

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

402

0.92

0.16

1.5

1.9

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

408

1.08

0.16

1.8

2.1

10.17

1091.50

u/ml

0.89

399

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.13

0.16

1.6

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.11

0.16

1.0

1.1

1614.50

1624.39

miu/ml

—

(3035637) Corticotropin [Mass/volume] in Plasma

341

1.09

0.15

1.8

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

111

1.17

0.15

1.8

1.92

8.66

nmol/l

0.98

(3032057) Clostridioides difficile [Presence] in Stool

0.79

0.15

2.3

1.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

121

1.16

0.15

1.6

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

713

1.05

0.14

1.2

4.58

7.19

u/ml

0.51

123

(3003694) ABO and Rh group [Type] in Blood

736

7456

0.98

0.14

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

606

1.06

0.14

1.2

—

0.62

—

(3005570) Glucose [Moles/volume] in Urine

316

0.92

0.14

2.0

—

(3005033) Fetal Nuchal fold Thickness US

139

0.86

0.14

1.7

1.4

—

(40768446) Kidney Pathology biopsy report

0.81

0.13

1.3

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

247

1.09

0.13

1.2

1.4

6.93

6.96

g/l

0.01

172

(3024139) IgG subclass 3 [Mass/volume] in Serum

247

1.09

0.13

1.2

1.4

0.57

0.43

g/l

0.28

171

(3028192) IgG subclass 2 [Mass/volume] in Serum

247

1.09

0.13

1.2

1.4

2.69

2.88

g/l

0.25

171

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

106

0.85

0.13

1.4

1.8

28.71

61.70

u/l

—

100

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

579

1.05

0.13

1.3

1.2

26.80

45.21

u/l

1.18

503

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

190

0.89

0.13

1.6

2.0

18.35

16.73

0.24

181

(3011648) Oxygen content in Venous blood

248

1.09

0.12

1.4

1.7

11.32

10.72

0.28

248

(4062490) Immunoglobulin typing, IgG

249

1.08

0.12

1.2

1.4

—

(3028433) Virus identified in Specimen by Culture

1.16

0.11

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

259

1.08

0.11

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

259

1.08

0.11

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

147

0.88

0.11

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

134

1.12

0.11

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

115

0.87

0.10

2.4

2.7

—

(44813793) Dust mix specific IgE antibody measurement

154

1.10

0.10

1.1

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

112

1089

1.03

0.09

1.1

200.83

167.96

titre

—

(3025941) Bacteria identified in Stool by Culture

154

1506

1.02

0.09

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.81

0.08

2.2

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.79

0.08

1.4

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.04

0.08

1.3

1.1

—

(3024932) HLA-DR beta [Type]

1.03

0.07

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

796

1.03

0.07

4.3

3.4

7.09

7.68

mmol/l

1.60

781

(3043238) Trisomy 21 risk [Likelihood] in Fetus

143

0.91

0.07

1.7

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

793

0.97

0.07

1.6

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.06

0.07

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.05

0.07

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

385

3810

1.01

0.07

3.2

4.0

4.37

25.67

ug/l

6.04

292

3156

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

173

0.92

0.06

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

173

0.92

0.06

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

173

0.92

0.06

1.6

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

173

0.92

0.06

1.6

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

217

2201

0.99

0.06

6.6

6.8

24.76

24.61

mmol/l

0.22

206

2089

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

244

0.94

0.06

1.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

345

3485

0.99

0.06

3.3

3.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

340

3367

1.01

0.06

1.4

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

303

0.96

0.05

1.4

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

110

1.09

0.05

1.3

1.1

239.51

223.41

iu/ml

0.05

110

(3023430) Cat dander IgE Ab [Units/volume] in Serum

171

0.94

0.05

1.0

1.1

5.93

4.31

u/ml

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

545

1.03

0.04

2.7

3.9

29.21

40.86

u/ml

0.60

535

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

343

0.96

0.04

1.2

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

343

0.96

0.04

1.2

1.4

—

(4281824) Cell count and differential, peritoneal fluid

339

1.03

0.03

1.1

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

139

0.94

0.03

1.6

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

118

0.93

0.02

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

848

1.01

0.02

2.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

188

0.96

0.02

1.0

0.99

2.70

u/ml

1.39

(3008037) Lactate [Moles/volume] in Venous blood

840

0.99

0.02

4.2

3.3

1.61

1.65

mmol/l

0.10

824

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

838

0.99

0.01

1.5

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

166

0.96

0.00

1.9

2.5

42.27

38.80

0.34

101

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

186

0.97

0.00

1.7

2.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

356

0.98

0.00

1.2

1.3

—

nmol/l

—

(3037756) Immunofixation for Serum or Plasma

814

1.01

0.00

1.7

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.02

0.00

1.4

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

138

1.01

0.00

1.1

1.3

173.91

164.01

pmol/l

0.09

138

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

185

0.97

0.00

2.2

43.00

114.96

ug/min

—

(3023419) Bacteria identified in Sputum by Culture

552

1.00

0.00

2.9

2.5

—

(3012516) Albumin [Mass/volume] in Urine

1005

10049

1.00

0.00

3.1

3.2

375.62

283.75

mg/l

0.27

615

6390

(3017315) Amylase [Enzymatic activity/volume] in Urine

159

1.01

0.00

1.3

1.2

168.50

306.97

u/l

1.01

146

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

306

1.01

0.00

1.1

1.3

5.97

7.86

mmol/l

4.93

252

(21494434) Karyotype in Bone marrow

327

1.01

0.00

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.8

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.95

-0.00

1.0

1.3

—

(3002619) Bacteria identified in Specimen by Culture

1.00

-0.00

1.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.99

-0.00

1.4

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.95

-0.00

1.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3000285) Sodium [Moles/volume] in Blood

0.95

-0.00

1.0

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

800

1.00

-0.00

1.4

1.6

0.01

0.26

iu/ml

2.56

170

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

0.20

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

3776.00

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

0.97

-0.00

1.7

1.3

2.78

3.42

umol/l

—

(3024471) HLA-A [Type]

1.01

-0.00

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.0

—

391.83

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.5

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

400

1.00

-0.00

1.2

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.6

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

16.99

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: MEMLOSS – Memory loss

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Memory loss

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Memory loss (MEMLOSS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints